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Chromatographic methods with chiral stationary phases (CSPs) are typically 
applied in the enantioseparation of chiral drug compounds. This dissertation 
focuses on synthesis and application of a series of novel antibiotic-capped 
macrocycle-bonded silica particles as CSPs in high-performance liquid 
chromatography (HPLC) and capillary electrochromatography (CEC) for 
enantioseparation of chiral drugs. Those novel CSPs were prepared by 
successive multiple step liquid solid phase reactions on silica gel surface. The 
synthetic stationary phases were characterized by scanning electron 
microscopy (SEM) with energy dispersive X-ray spectrometry (EDS), mass 
spectrometry (MS), elemental analysis and Fourier-transform infrared 
spectroscopy (FTIR). The CSPs have multiple chiral recognition sites with 
many different functional moieties including vancomycin, rifamycin, 
β-cyclodextrins and types of calixarenes. Due to the cooperative function of 
the antibiotics and the anchored macrocycle moieties, the new CSPs exhibited 
excellent chromatographic selectivity for separation of positional isomers of 
some disubstituted benzenes and enantiomers of a wide range of chiral drugs 
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1.1 Chirality and enantiomers 
 
The word chirality is derived from the Greek “chrei” (χεíρ, meaning hand) to 
reflect an important property of asymmetry in many fields of science. In 
chemistry, it is the property that one molecule possesses a non-superimposable 
mirror image. In other words, a molecule is chiral meaning it is not identical or 
not superposed to its mirror image. In stereochemistry, enantiomers are two 
molecules which have same chemical bond (i.e. same formula and 
connectivity) but different spatial arrangement of atoms. In simple terms, a 
pair of enantiomers refers to a chiral molecule and its non-superimposable 
mirror image molecule.  
 
The history of enantiomer discovery can be traced back to the early 19th 
century when Biot observed that tartaric acid could rotate polarized light 
which subsequently lead to the discovery of its optical isomers. This discovery 
was further affirmed by Pasteur who established the chirality of tartaric acid 
molecule (Pasteur, 1848). Later, the existence of asymmetric carbon atom was 
proposed by Van't Hoff and Le Bel who used it to explain the optical rotation. 
The initial attempt for the stereochemistry of optical isomers was made by 
Fischer, who received the Nobel Prize in 1902 for his contribution to 
determine the configuration of (+)-glucose. Fisher’s assumption in 
stereochemical structure of glyceraldehyde was later proved by Bijovet using 
X-ray crystallography. The foundations of chiral chemistry were established 
by that time, and the study of stereochemistry progressed slowly thereafter but 
steadily in the following decades (Beesley and Scott, 1998).  
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For a pair of enantiomers, they essentially possess identical physical properties 
(except for optical rotatory) and chemical properties (except in a chiral 
environment). These little differences seem to be ignored but may cause 
significant difference under a chiral environment. One interesting example is 
the two enantiomers of carvone,  2-methyl-5-(1-methylethenyl)- 
2-cyclohexenone, which are perceived as different odors (Leitereg, 1971). As 
shown in Fig. 1.1, (R)-carvone is the substance responsible for the smell of 
spearmint oil while (S)-carvone, the major flavor component of caraway seeds, 
is responsible for the characteristic aroma of rye bread.  
 
 
Fig. 1.1. Enantiomers of Carvone.   
              
       (S)-carvone has caraway odour but (R)-carvone has spearmint odour. 
 
At the molecular level, chirality is an intrinsic property of ‘‘life building 
blocks’’ such as amino acids, saccharides and nucleic acids. Interestingly, these 
molecules predominantly exist in only one of the two possible enantiomeric 
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forms. Such homochirality of biomolecules gives rise to the phenomenon that 
most peptides, proteins and even biological systems possess chiral selectivity. 
Consequently, metabolic and regulatory processes mediated by biological 
systems are sensitive to chiral selectivity with different responses from a pair 
of enantiomers (Maier, 2001). In the case of carvone, the different odors from 
two enantiomers indicates that olfactory receptors possessing chiral selectivity 
which allows them to respond differently. Furthermore, biological systems 
sometimes show similar response to a pair of enantiomers but with different 
strength.  
 
It is worth nothing that human body acts in a chiral environment with 
amazingly chiral selectivity, i.e. biological systems (in human body) may 
interact with a pair of enantiomers differently and metabolize each enantiomer 
by a separate pathway to produce different pharmacological activities. 
Therefore, the effects of the enantiomers of chiral pharmaceuticals are often 
readily distinguished in human body where they exhibit different 
pharmacokinetic properties such as absorption, distribution, metabolism and 
excretion (ADME profile) with different pharmacologic or toxicologic effects. 
In other words, one enantiomer (eutomer) is usually more active for a given 
action, while the other (distomer) might be active in a different way, 
contributing to side-effects, displaying toxicity, or acting as antagonitst (Ariëns, 
1984). The chiral pharmaceuticals mentioned in Table 1.1 are typical examples 




Table 1.1. Effect of chirality on pharmaceutical efficacy. 
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The mechanism of chiral selectivity can be explained by the “Lock and Key” 
analogy which is schematically illustrated in Fig. 1.3. Briefly, one enantiomer 
as a “Key” may interact with a specific receptor by fitting the active site of a 
specific enzyme as a “Lock” to initiate a response. The other enantiomer, 
however, may not interact with this receptor because of poorer binding with 
the same site due to the different spatial arrangement of atoms. Moreover, it 
may interact with another receptor by fitting to a different enzyme active site 
to trigger a different response which maybe undesired side effects, or 




Fig. 1.2. The interaction of chiral molecules with biological receptors.  
 
        (a) enantiomer fits receptor sites leading to a response;  
        (b) enantiomer does not fit receptor sites, no response. 
 
One typical example of the different biological responses caused by the 
different enantiomers is the thalidomide tragedy which is one of the darkest 
episodes in pharmaceutical history. Thalidomide was first marketed in 1956 by 
German pharmaceutical firm Chemie Grünenthal and then banned worldwide 
in 1962. It was primarily prescribed as an antiemetic and sedative drug to 
against nausea and alleviate morning sickness for pregnant women. Tragically, 
over 10,000 children in 46 countries were born with deformities like 
phocomelia due to the thalidomide use during such few years. This disaster 
drew the attention of the drug regulatory committees worldwide to implement 
strict rules to test and license drug, such as the U.S. Kefauver Harris 
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Amendment and Directive 65/65/EEC1, the first European pharmaceutical 
directive.  
 
From a chemical point of view, the thalidomide molecule has one chiral 
carbon and thus may exist in two enantiomeric forms as shown in Fig. 1.2. 
Among the two enantiomers of thalidomide, only (R)-thalidomide is effective 









Generally, drug action is the result of pharmacological and pharmacokinetic 
processes. There is a broad range of examples where the enantiomers of drugs 
exhibit differences in bioavailability, distribution, metabolic and excretion 
behavior and where stereochemical parameters play fundamental significance 
in their actions and disposition in biological systems (Maier, 2001). 
 
In 1992, the U.S. Food and Drug Administration issued a guideline that only 
the therapeutically active enantiomer of a chiral drug can be brought into 
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market. In addition, each enantiomer of chiral drug compounds should be 
studied separately for its pharmacological and metabolic pathways. Therefore, 
manufacturers must develop quantitative assays for enantiomers individually 
in in vivo samples during drug development to evaluate pharmacokinetics, 
which will lead to assessment of the potential of interconversion and the 
ADME profile of individual enantiomers. If a candidate drug product is 
racemic with different pharmacokinetic profiles from its enantiomers, 
manufacturers have to monitor the pharmacological effects of the enantiomers 
individually so as to measure the properties such as dose linearity, effects of 
altered metabolic or excretory function and drug-drug interactions.  
 
Since a pair of enantiomers have almost identical properties, special chiral 
techniques are usually required for their separation, quantitation and 
sometimes identification. Among them, enantioseparation, to separate 
enantiomers based on their subtle differences in properties, is in a decisive 
position. Enantioseparation can be applied in simultaneous production of both 
enantiomers (dual-isomer recovery) or only the target enantiomer 
(single-isomer recovery). The former is often used in the manufacture of chiral 
intermediates as both enantiomers are of market outlets. The chiral technology 
selects one enantiomer, leaving the other behind and both are ultimately 
recovered by conventional means. The latter is usually applied to the 
manufacture of end-use chemicals or intermediates when only one enantiomer 
is commercioganic. The chiral technology can also select the target enantiomer 
while deliberately racemizes the other enantiomer and recycles it in the 
selection process to produce the target enantiomer. 
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The large demand of enantiomerically pure products has stimulated the 
progress of enantioseparation, which is considered as one of the most important 
areas of research in both industry and academia during the last decades. Beside 
pharmaceutics and medicinal sciences, enantioseparation also received more 
and more attention in geochemistry (Eglinton and Calvin, 1967), 
geochronology (Helfman and Bada, 1975), biochemistry and materials science 





In the early 20th century, chemists were limited to laboratory techniques such 
as crystallization, liquid-liquid distribution and distillation for separations. 
New techniques were required to rapidly isolate pure components from natural 
products and to support the development of increasingly sophisticated 
approaches for organic synthesis (Poole, 2003). Tswett first used a column 
consisted of calcium carbonate powder to separate green leaf pigments into a 
series of coloured bands by using solvent to percolate through the column bed 
(Tswett, 1905). He also introduced the term “chromatography” which is coined 
from the Greek “chroma” (χρῶμα) meaning colour and “graphein” (γράφειν) 
meaning to write (Tswett, 1906). However, chromatography was not an instant 
success and it became an established laboratory method after a few decades 
later until its rediscovery. Nowadays, chromatography has become the most 
powerful and diversified separation technique in chemistry.  
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Chromatography is essentially a method of separation that sample components 
are separated by distribution between two phases, one phase (mobile phase) 
moves with respect to the other (stationary phase). Chromatographic 
separation requires adequate difference in the interaction strength for sample 
components with two phases, combined with the contribution from system 
transport properties which control the movement within and between two 
phases. The milestones in the evolution of chromatographic separation 
technique are listed in Table 1.2 (Poole, 2003). 
 
Table 1.2. Significant landmarks in the evolution of chromatography. 
 




Original description of column liquid chromatography by Tswett. 
1931 Rediscovery of column liquid chromatography by Lederer. 
1938 Ion-exchange column liquid chromatography introduced. 
1941 Column liquid-liquid partition chromatography introduced. 
1944 Paper chromatography introduced. 
1950s 
 
Thin-layer chromatography (TLC) became popular with immobilized 
layers and standardized sorbents. 
1962 Supercritical fluids introduced as mobile phase by Klesper. 
1960s 
 
Pellicular sorbents introduced as stationary phase in high-pressure 
liquid chromatography (HPLC).  
1984 
 
Micellar electrokinetic chromatography introduced to use buffers in 
capillary electrophoresis (CE) apparatus. 
1980s Rediscovery of capillary electrochromatography (CEC). 
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The compounds in chromatographic separation are distinguished by their 
ability to participate in the intermolecular interactions within mobile phase and 
stationary phase. Different transports through stationary phases from diffusion, 
convection, turbulence, etc., lead to the dispersion of solute zones around an 
average value. Therefore, each component occupies a finite distance along 
stationary phase in the direction of migration. Meanwhile, the extent of 
dispersion restricts the capacity of chromatographic system to separate. 
Independent of favorable thermodynamic contributions to separation, there are 
number of dispersed zones which can be accommodated during the separation. 
Consequently, chromatographic separations depend on a favorable 
contribution from thermodynamic and kinetic properties of compounds to be 
separated.  
 
A convenient classification of chromatography is made in terms of the 
physical state of phases employed during separation. When the mobile phase is 
a gas, this kind of separation techniques is known as gas chromatography (GC). 
Similarly, liquid chromatography (LC) refers to the chromatographic 
techniques using liquid as mobile phase (Poole, 2003). Compared with LC, 
GC is mainly used for volatile samples and not very suitable for thermally 
labile samples. Based on the wide range of separation mechanisms, 
chromatography can be further divided into gas-solid chromatography, 
gas-liquid chromatography, liquid-liquid chromatography, supercritical fluid 
chromatography, micellar electrokinetic chromatography, size exclusion 
chromatography, ion-exchange chromatography, affinity chromatography, 
capillary electrochromatography (CEC), etc.  
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The essential part of a chromatographic system is the column that contains 
stationary phase over which mobile phase flows, and where the separation of 
mixture into individual components occurred. The sample is introduced into 
the column by injection device and the separated components are monitored 
by a suitable detection system. LC separations are completely dominated by 
using bonded phase materials which is integrated with the support, mainly 
silica, as stationary phase. As the rapid development of ligands that are 
chemically or physically attached to the silica surface , a great variety of 
stationary phases are currently available. The length of packed LC columns is 
usually less than 30 cm, since the particle seize (2~10 μm diameter) of packing 
materials results in back-pressure which precludes the use of longer columns. 
The solvent delivery system is also important for LC instrument. Since 
high-efficiency columns usually produce significant back-pressure, 
high-pressure pump must be employed to force mobile phase through the 
column with a controlled flow rate. UV-detector is the standard detector for 
LC, particularly with the variable wavelength version covering the range 
190~350 nm. In addition, the diode-array detector makes it possible to obtain a 
complete UV-spectrum from any part in the chromatogram (Poole, 2003). 
 
 
1.4 Chiral Chromatography 
 
For enantioseparation, the most successful method is introducing an 
enantiomeric reagent to induce specific selectivity, in other words, to exploit 
the differential interactions with enantiomers based on their unique spatial 
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orientation. Currently, chiral chromatography is the most direct and technically 
viable way to achieve satisfied resolution of a wide variety of chiral 
compounds. The enantiomers with different spatial arrangement are selectively 
retained in the chromatographic system by specifical interaction with 
enantiomeric reagent. The precise mechanism of the selective retention for a 
specific enantiomer is very complicated. By far, modern chromatographic 
apparatus with extremely high efficiency is the most effective approach for 
analytical purposes. Meanwhile, for enantiomer purification, some other 
approaches including destruction of the unwanted enantiomer in racemic 
mixture by enzymatic reactions, and crystallization from racemic mixture are 
remain important but often combined with chromatography methods. 
 
From 1980s, the commercial interest in chiral substances, especially chiral 
drugs, had suddenly increased. The major stimulation arose from the 
thalidomide disaster. The mandate to test each enantiomer of chiral drugs 
evoked the need for appropriate analytical procedures to separate and 
quantitatively assay. Nowadays, high-performance liquid chromatography 
(HPLC) is the most popular and highly applicable technology in the field of 
chiral analysis (Subramanian, 2007). It can be used to separate enantiomers 
either indirectly with chiral derivatization reagents, or directly with chiral 
mobile phase additives (CMPAs) or chiral stationary phases (CSPs).  
 
The indirect separation is based on the formation of diastereomer complexes 
between enantiomers and suitable chiral derivatization agents by pre-column 
derivatization, with subsequent separation by an achiral chromatographic 
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method. One prerequisite for this method is the analytes has easy 
derivatization functional groups, such as carboxylic, carbonyl, amino or 
alcoholic (Dołowy and Pyka, 2015). This method is not very practical since 
derivatization requires additional steps which include undesirable side 
reactions, formation of decomposition products and racemization. Meanwhile, 
chiral derivatization reagent has to be high enantiomerically pure (Cavazzini et 
al., 2011). For direct separation, the enantiomers are resolved by forming 
transient diastereomer association complexes with a chiral selector either 
immobilized in stationary phase (i.e. CSP) or added into mobile phase (i.e. 
CMPA). The advantages of this method include decreased analysis time, easier 
sample preparation, simultaneous determination of chemical and chiral purity 
analysis. In addition, this method is also available for enantiomers which are 
lack of reactive functional groups.  
 
To achieve a successful direct enantioseparation in HPLC, an enantioselective 
environment must be created by the addition of chiral selector(s) in the 
separation system. Many enantiomers can be separated on conventional achiral 
LC columns by employing appropriate CMPAs. However, compared with 
using CSPs, this method is complicated and costly. In addition, it is 
inconvenient for preparative applications since CMPAs must be removed from 
the separated eluents afterward. Generally, CMPAs are dominant in capillary 
electrophoresis (CE) whereas CSP is the only choice for GC and almost 
dominated in the practice of LC. The details for different direct methods for 
enantioseparation in chromatography are shown in Table 1.3. 
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Table 1.3. Direct methods for enantioseparation in chromatography. 
 







amino acid derivatives 
metal chelates 
cyclodextrin derivatives 











amino acid derivatives 










amino acid derivatives 
proteins 





1.5 Chiral Stationary Phase 
 
For direct separation of enantiomers by LC, the majority of published methods 
using CSP instead of CMPA though both techniques proved to be quite 
comparable. The high speed, sensitivity and reproducibility of CSPs make 
HPLC the key method for drug development in pharmaceutical industries, 
pesticide development in agricultural industries, preparation of food additives, 
natural product research, agrochemicals and pollutant analysis. 
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CSPs can be bonded to solid supports or created in situ on the surface of solid 
adsorbent for specific interactions with enantiomers. In 1966，the first CSP 
was reported to separate derivatized amino acid enantiomers (Gil-Av et al., 
1966). Subsequently, chiral crown ethers was utilized as CSP in 
enantioseparation of α-amino acids and ester salts (Sogah and Cram, 1976). 
Today, cyclodextrins (CDs) is one of the most commonly used chiral agents in 
chromatography which was first introduced as chiral separation agents 
(Harada et al., 1978) and later used as CMPAs in HPLC (Armstrong and Henry, 
1980).  
 
Until the early 1980s, there is few commercial CSPs in LC (and GC) for 
enantioseparation. However, the development of CSPs is growing rapidly in 
the last 30 years. Nowadays, there are over hundred commercial CSPs 
immobilized with different chiral recognition sites selectors. Based on the 
chemical characteristics of the chiral selectors employed, nowadays CSPs can 
be roughly divided into several classes: CDs and derivatives, macrocyclic 
antibiotics (including macrocyclic glycopeptides), polysaccharide (including 
cellulose or amylose), protein, brush-type (or Pirkle-type), ligand-exchange, 
etc. as shown in Table 1.3 (Subramanian, 2007). Among them, most 
enantioseparations can be achieved on the CD-based or macrocyclic 
glycopeptides-based CSPs. 
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Table 1.4. Types of CSPs. 
 
Type Examples Molecular interactions favoring chiral recognition Mobile phase mode 
 





(strong) inclusion complex, hydrogen bonding, steric 
interactions; (weak) hydrophobic interaction 
 
reversed-phase 







(strong) π-π interaction, hydrogen bonding, dipole-dipole 









(strong) π-π interaction; (weak) hydrogen bonding, 
dipole-dipole interaction, steric interaction 
 
reversed-phase 







(strong) π-π interaction, hydrogen bonding; (weak) 



















electrostatic, hydrogen bonding, π-π interaction 
 
reversed-phase 






























1.6 Research objectives and hypothesis 
 
Currently, there is no shortage of commercial CSPs, however, there is no 
single CSP that can be considered universal, i.e. capable to separate all classes 
of chiral compounds. An ideal CSP should fulfill the requirements on 
efficiency, selectivity, operation mode, robustness, compatibility, loadability 
and reproducibility. Among the functional-moieties for preparing CSPs, crown 
ethers and CDs, the two main kinds of host molecules, exhibited excellent 
enantioseparation performance for several different categories of chiral 
compounds. Calixarenes, a type of synthetic molecule that possesses similar 
structure and property to crown ethers and CDs but contains more reactive 
functional groups, has great potential to become the new generation of host 
molecules in host-guest chemistry. Therefore, it is our interest to develop 
novel CSPs employing cailxarenes as the chiral recognition moieties. 
 
Currently, most commercial CSPs are based on single chiral recognition site 
(e.g., β-CD or vancomycin). In addition, most research work on CSPs focus on 
modification of commercial CSPs or derivatization of CSPs with single chiral 
recognition site. Our group previously developed a series of β-CD-based CSPs 
with multiple chiral recognition sites and successfully applied them in LC for 
enantioseparation for a wide range of chiral compounds (Gong and Lee, 2002; 
Gong et al., 2003a, b; Thamarai et al., 2008). These experiences motivated us 
to develop novel CSPs with multiple chiral recognition sites to provide 
multiple interactions with chiral solutes to enhance chiral recognition. 
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This dissertation will focus on CSPs based on macrocyclic host molecules 
(calixarenes, β-CD, crown ethers) and macrocyclic antibiotics (vancomycin 
and rifamycin). The hypothesis of this study is that the new types of 
antibiotic-capped macrocycle-bonded CSPs are superior to commercial CSPs 
in achieving high enantioselectivity for chiral drugs for a wider range of chiral 
drugs in LC, due to cooperative function of the novel multiple chiral 
recognition sites in the new CSPs. 
 
The main objective in this study is to develop a series of novel 
antibiotic-capped β-CD/MCR-bonded silica particles and applied as CSPs in 
LC to develop enantioseparation techniques with high selectivity and high 
efficiency. The novel CSPs with multiple chiral recognition sites (i.e. β-CD, 
calixarenes, crown ether, vancomycin and rifamycin) would be synthesized via 
a successive multiple step liquid-solid phase reaction on silica. The packed 
HPLC and CEC columns with new CSPs would be evaluated by positional 
isomers and applied to the separation for a wide range of chiral compounds 
including amino acid, β-blockers, non-steroidal anti-inflammatory drugs 
(NSAIDs), pharmaceutical intermediates and other chiral drugs. The 










SYNTHESIS OF NOVEL MACROCYCLIC-BONDED 




Nowadays, there are plenty of different materials employed as CSPs in LC 
which are generally prepared by bonding or coating various chiral selectors 
onto silica support. In this chapter, CDs, calixarenes, vancomycin and 




2.1.2 Cyclodextrins and calixarenes 
 
Both CDs and calixarenes are common host molecules for host-guest complex 
formation which mainly encompasses molecular recognition and interactions 
through non-covalent bonding interactions, i.e. ionic interactions, hydrogen 
bonds, π-π interaction, van der Waals forces and hydrophobic effects. In 
addition, the charge and polarity of guest component also influence complex 
formation. Briefly, highly water-soluble, highly hydrophilic and therefore 
highly hydratable guest components are not suitable for complex formation. 
The factors affecting complex formation cannot be accurately predicted and 
must be re-evaluated and experimentally studied for each guest component.  
 
CDs is a kind of cyclic oligomers consisted of five or more 
α-D-glucopyranosides units via α-1, 4 linkages. As the product from starch by 
enzymatic conversion, natural CDs is biocompatible and do not elicit immune 
responses with low toxicities to human. The natural α-CD, β-CD and γ-CD 
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consist of six, seven, and eight glucopyranose units respectively. The 
molecular shape of CDs can be roughly described as a hollow truncated cone 






































Fig. 2.1. Structure of β-CD. 
 
The cone shape of CDs make it is possible to form host-guest complexes. CDs 
act as the host to various guest components, which are stabilized in the cavity 
of CDs molecules by intermolecular interactions. Generally, CDs is able to 
form water-soluble inclusion complexes with small molecules and portions of 
large molecules by van der Waals forces. Guest components, which are able to 
form host-guest complexes with CDs, vary greatly in structure, from 
hydrophobic substances such as alkanes and aromatic hydrocarbons to polar, 
organic substances and simple anions. If guest components contain hydroxyl 
groups or other groups which are able to form hydrogen bonds, the complex 
would be significantly stabilized. Since intermolecular interactions are 
strengthened by hydrogen bonding between guest component and the hydroxyl 
groups of CDs molecule. The size of guest component (in relation to the cavity 
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size of CDs) is the most important factor for host-guest complex formation. If 
guest component is too small, the distances between guest component and 
interior of CDs molecule are too long to form intermolecular forces. On the 
contrary, if guest component is too large, complex formation cannot take place 
due to steric hindrance. For example, toluene can form host-guest complex 
with α-CD and β-CD but is too small for γ-CD, whereas naphthalin is too big 
for α-CD but can form host-guest complex with β-CD and γ-CD. It is notable 
that sometimes just parts of guest component can be complexed within the 
cavity of CDs.  
 
Calixarenes is a kind of cavity-shaped cyclic molecules made up of phenol 
units linked via alkylidene groups. The calixarene molecule is characterized by 
one wide upper rim, one narrow lower rim and one central annulus with one 
hydrophobic cavity which is able to form inclusion with smaller ions or 
molecules. The word calixarene is derived from “calyx” (or chalice), since the 
molecule structure similar to a vase, and from the word “arene” referring 
aromatic building blocks. The nomenclature of calixarene is straightforward to 
count the number of repeating units in the ring and include it in the name, i.e.  
calix[4]arene has four units in the ring. The substituent in meso position is 
added to the name with a prefix C- as in C-methylcalix[4]resorcinarene 
(MCR). Calixarenes is the hydroxyalkylation product of aldehydes and 
phenols and may exist in different chemical conformations due to rotation of 
methylene bridge. For a calix[4]arene molecule, the four hydroxyl groups are 
intra-annular on the lower rim and interact by hydrogen bonding and thus the 
cone conformation is stabilized. This conformation is in a dynamic 
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equilibrium with other conformations which can be locked with substituent by 
replacing hydroxyl groups to increase the rotational barrier. For MCR 
molecule, there are eight hydroxyl groups placed as extra-annular on the upper 




















Fig. 2.2. Structure of Calix[4]arene (left) and MCR (right). 
 
 
2.1.2 Vancomycin and rifamycin 
 
Macrocyclic antibiotics is not only an additional class of chiral selector in 
separation science producing similar separations to CDs, but offers unique 
properties for resolution of many categories of compounds with better 
selectivity. Every macrocyclic antibiotic molecule possesses a number of 
chiral centers and functional groups prividing multiple interactions with chiral 
molecules. Up to now, glycopeptides and ansamycins are the most successful 




Vancomycin is used to treat a number of bacterial infections. The generic 
name vancomycin is derived from the tem vanquish. It belongs to the class of 
glycopeptides, consisted of an aglycon portion of fused macrocyclic rings to 
form characteristic basket shape and carbohydrate moieties attached to the 
aglycon basket, which usually contains three or four fused macrocyclic rings 
composed of linked amino acids and substituted phenols. The carbohydrate 
moieties are consisted of carbohydrate or saccharide groups. The sugar groups 
attached to aglycon basket are free to rotate and able to assume a variety of 
orientations. There are two side chaims (one carbohydrate dimer and one 
N-methylamino acid), three macrocyclic portions, five aromatic rings, nine 
hydroxyl groups, two amine groups, seven amido groups, two chlorine 
moieties with totally eighteen chiral centers in a vancomycin molecule as 
shown in Fig. 2.3. Such structure with multiple functional groups allow for 




Fig. 2.3. Structure of Vancomycin. 
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Rifamycin is a group of macocyclic antibiotics and particularly effective 
against mycobacteria. It belongs to the class of ansamycins with the 
characteristic unique ansa structure consisted of a ring structure or 
chromophore spanned by an aliphatic bridge. The aliphatic chain can be highly 
substituted and thus rifamycins differ from each other by type and position of 
the substituent on the naphthohy-droquinone ring. Among them, rifamycin SV 
is the first member in this class for clinical use as an intravenous antibiotic. 
There are two aromatic rings, five hydroxyl groups, one amido group with 
totally nine chiral centers in a rifamycin SV molecule as shown in Fig. 2.4. 
Similar to vancomyin, the multiple functional groups in rifamycin SV 




























2.1.3 Novel CSPs with multiple recognition sties 
 
Among the common host molecules, crown ethers and CDs are the two main 
kinds with most study and applications including used as CSPs. Up to now, a 
lot of enantioseparations have been accomplished by using ß-CD-based CSPs 
in Chiral LC (Ong et al., 2008). However, one drawback of utilizing CDs is 
the relative low binding constants for lots of guest molecules (Park et al., 
2000).  
 
Calixarenes has similar cavity structure and metal-ammonium cation binding 
properties as crown ethers (Abidi et al., 1996), and also exhibits excellent 
inclusion abilities for many guest molecules (Ananchenko et al., 2008). By far, 
several types of modified calix[4]arene were successfully used as CSPs in LC 
for enantioseparation (Thamarai et al., 2008). Meanwhile, vancomycin is of 
similar cavity structure, metal ion binding property and even better binding 
properties for a lot of guest molecules to crown ethers (Zhao et al., 2010b). It 
was first used as chiral selector in HPLC (Armstrong et al., 1994). Nowadays, 
there is commercial vancomycin-based CSP available (Chirobiotic V). For 
rifamycin SV, it was reported as chrial selector in CE (Ward, 1995). Due to the 
high UV/vis absorption characteristics and poor solubility in water, antibiotic 
macrocyles and their derivatives are unsuitable for CMPAs, alternatively, can 
be bonded on support applied as CSPs (Zhao et al., 2010a).  
 
Interestingly, a novel mixed stationary phase was reported which contains 
substituted calix[4]arene, 18-crown-6 and β-CD as three recognition sites (Xu 
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et al., 1999). The synergistic effect in such stationary phase from the 
cooperative function of recognition sites greatly improves the separation 
selectivity in chromatography. In addition, β-CD was reported to use as CMPA 
for vancomycin-based CSP in LC achieved better enantioseparation 
performance for duloxetine than vancomycin-based CSP alone resulting from 
the cooperative function of β-CD and vancomycin (Yang, 2007). Meanwhile, 
β-CD-derivatized erythromycin was reported as chiral additives in CE and 
provided better enantioseparation performance than using erythromycin or 
β-CD alone (Dai, 2007).  
 
Therefore, it is interfering for us to develop novel antibiotic-capped 
β-CD/MCR-bonded silica particles as CSPs which have multiple recognition 
sites and may exhibit better enantioseparation performance than the crown 
ethers/cyclam-capped β-CD-based CSPs previously reported by our group 





2.2.1 Regents and materials 
 
The chemicals, reagents and solvents used to prepare novel 
macrocycle-bonded silica stationary phase and chromatographic experiments 
were supplied pure or repurified if necessary.  
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LiChrosphere® Si 60 (5 μm, 100 Å) was obtained from Merck (Darmstadt, 
Germany) and premium Rf spherical silica (3 μm, 100 Å) was purchased from 
Sorbent Technologies (Atlanta, GA, USA). All silica was activated by 
refluxing in hydrochloric acid (4%) for 2 h to remove alkoxy group, and then 
washed by distilled water until the washing solution becoming neutral. After 
drying in vacuum, the silica was kept in the desiccator before synthesis. 
 
Calix[4]arene (M = 424.49) and MCR (M = 544.58) were purchased from 
Fluka (Buchs, Switzerland). β-cyclodextrin (β-CD, M = 1135.01), vancomycin 
hydrochloride (M = 1485.71) and Rifamycin SV sodium salt (M = 719.75), 
1-aza-15-crown-5 (15C5, M = 219.28) were purchased from Sigma (St. Louis, 
MO, USA). 3-glycidoxypropyltrimethoxysilane (GPS, M = 236.34, ρ = 1.07) 
was obtained from Merck (Hohenbrunn, Germany). Bromoacetyl bromide (M 
= 201.86, ρ = 2.324) and bromoacetyl chloride (M = 157.39, ρ = 1.89), sodium 
hydride (NaH, M = 24), potassium carbonate (K2CO3) and aluminum chloride 
(AlCl3) were purchased from Sigma (St. Louis, MO, USA). 
 
Anhydrous N-methyl-2-pyrrolidone (NMP) was purchased from J. T. Baker 
(Phillipsburg, NJ, USA). Anhydrous toluene, N,N-Dimethylformamide (DMF), 
triethylamine (TEA, M = 101.19, ρ = 0.728), tris(hydroxymethyl)- 
aminomethane (Tris), hydrochloric acid and acetic acid were purchased from 
Sigma (St. Louis, MO, USA). HPLC-grade solvents acetonitrile (ACN), 
acetone, dichloromethane (DCM), hexane, isopropanol (IPA) and methanol 
(MeOH) were obtained from Merck (Darmstadt, Germany). Ultrapure water 




Analytical grade o-, m-, p-nitrophenols and o-, m-, p-nitroanilines were 
purchased from Fluka (Buchs, Switzerland). Analytical-grade chiral 
compounds (1S,2R)-2-amino-1,2-diphenylethanol, aminoglutethimide, 
benzylmandelate, dichlorprop, ibuprofen, indapamide, indoprofen, ketoprofen, 
labetalol, methylmandelate, α-methylbenzylamine, metoprolol, nadolol, 
1-(1-naphthyl)ethano, 1-(1-naphthyl)ethylamine, phenylalanine, 
1-phenyl-1-propanol, 1-phenyl-2-propanol, pindolol, proglumide, 
promethazine, propranolol, tyrosine, warfrain were purchased from 





Scanning electron microscopy (SEM) was completed by the Jeol JSM-6610LV 
(Tokyo, Japan) instrument. An Oxford Instruments INCAx-act (Oxford, UK) 
was used for energy dispersive X-ray spectrometry (EDS) analysis. Mass 
spectrometric (MS) was performed on the Agilent Technologies (Waldbronn, 
Germany) G2445A ion-trap mass spectrometer coupled with electrospray 
ionization (ESI) source operated at positive mode. Elemental analysis was 
performed on the Perkin Elmer (Norwalk, CT, USA) 2400 elemental analyzer. 
Fourier-transform infrared spectroscopy (FTIR) was conducted by using the 
Bio-Rad (Hercules, CA, USA) Model FTS165 instrument. 
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2.2.3 Synthesis of modified ß-CD-bonded silica particles 
 
2.2.3.1 Synthesis of (3-(2-O-ß-cyclodextrin)-2-hydroxypropoxy)-propylsilyl- 
bonded silica particles (CD-HPS) 
 
Briefly, CD-HPS was synthesized by anchoring ß-CD onto silica particles in 
anhydrous DMF with the presence of GPS under nitrogen (Gong and Lee, 
2002). The scheme of synthesis is shown in Fig. 2.5. Typically, 5.67 g of ß-CD 
(5 mmol), previously dried under vacuum at 120 °C for over 12 h, was 
dissolved in 100 mL of anhydrous DMF. Then, 0.2 g of 60% NaH (5 mmol) 
was added into the solution which would be stirred at room temperature until 
becoming clear. Next, 1.1 mL of GPS (5 mmol) was added and the mixture 
was stirred continuously at 70 °C for 4 h. Afterwards, 5 g activated silica (3 
μm or 5 μm), previously dried under vacuum at 120 °C for over 12 h, was 
added and the reaction was continued at 70, 80, 90, 100 °C for 1 h each and 
110 °C for 20 h. Finally, the product CD-HPS was filtered and washed 
successively with DMF, MeOH, water and acetone, then purified by Soxhlet 
extraction using acetone for 12 h.  
 
 
2.2.3.2 Synthesis of bromoacetate-substituted (3-(2-O-ß-cyclodextrin)-2- 
hydroxypropoxy)-propylsilyl-bonded silica particles (BACD-HPS) 
 
Briefly, BACD-HPS was synthesized by treatment of CD-HPS with excess 
bromoacetyl bromide in anhydrous DCM with the presence of TEA under 
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nitrogen (Gong and Lee, 2002). The scheme of synthesis is shown in Fig. 2.5. 
Typically, 2 g of CD-HPS (prepared from 3 or 5 μm silica), previously dried 
under vacuum at 60 °C for over 12 h, was suspended in 80 M of anhydrous 
DCM. Then, one drop of TEA was added into the reaction mixture which 
would be stirred continuously in an ice bath while 0.2 mL of bromoacetyl 
bromide (2.3 mmol) in 40 mL of anhydrous DCM was added drop by drop for 
over 2h. Afterwards, the reaction was continued for 24 h at room temperature. 
Finally, the product BACD-HPS was filtered and washed successively with 
DCM, MeOH, water and acetone, then purified by Soxhlet extraction using 




























Fig. 2.5. Synthesis of CD-HPS and BACD-HPS. 
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2.2.3.3 Synthesis of vancomycin-capped (3-(2-O-ß-cyclodextrin)-2- 
hydroxypropoxy)-propylsilyl-bonded silica particles (VCD-HPS) 
 
Briefly, VCD-HPS was synthesized by treatment of BACD-HPS with excess 
vancomycin in anhydrous MeOH with the presence of K2CO3 under nitrogen 
(Zhao et al., 2010b). The scheme of synthesis is shown in Fig. 2.6. 
Vancomycin is proposed to attach the β-CD in BACD-HPS mainly through the 
reaction of phenolic groups with bromoacetate in BACA-HPS. The linkage 
showed is only an illustration since vancomycin may bond to β-CD through 
any phenolic groups. Typically, 0.95 g of vancomycin hydrochloride (0.64 
mmol), previously dried under vacuum at 80 °C for over 12 h, was dissolved 
in 100 mL of anhydrous MeOH with 10 mg of K2CO3. Afterwards, 2 g of 
BACD-HPS (prepared from 3 μm silica), previously dried under vacuum at 
60 °C for over 12 h, was added into the reaction mixture which would be 
stirred continuously and refluxed (around 65 °C) for 24 h. Finally, the product 
VCD-HPS was filtered and washed successively with MeOH, water and 
acetone, then purified by Soxhlet extraction using acetone for 12 h. 
 
 
2.2.3.4 Synthesis of rifamycin-capped (3-(2-O-ß-cyclodextrin)-2- 
hydroxypropoxy)-propylsilyl-bonded silica particles (RCD-HPS) 
 
Briefly, RCD-HPS was synthesized by treatment of BACD-HPS with excess 
rifamycin SV in anhydrous ACN with the presence of K2CO3 under nitrogen 
(Zhao et al., 2010a). The scheme of synthesis is shown in Fig. 2.6. Since 
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rifamycin molecule has only one amido group (or second acyl-amine group, 
–CO–NH–) which is more reactive than other functional groups, rifamycin is 
proposed to attach the β-CD in BACD-HPS via the reaction of amido group 
with bromoacetate in BACD-HPS. Typically, 0.98 g of rifamycin SV sodium 
salt (1.36 mmol), previously dried under vacuum at 80 °C for over 12 h, was 
dissolved in 50 mL of anhydrous ACN with 10 mg of K2CO3. Afterwards, 2 g 
of BACD-HPS (prepared from 3 μm silica), previously dried under vacuum at 
60 °C for over 12 h, was added in to the reaction mixture which would be 
stirred continuously and refluxed (around 82 °C) for 24 h. Finally, the product 
RCD-HPS was filtered and washed successively with ACN, MeOH, water and 



























































































Rifamycin SV      ACN
 
Fig. 2.6. Synthesis of VCD-HPS and RCD-HPS. 
 
The linkage between vancomycin and β-CD is only an illustration 
since vancomycin may bond to β-CD through any phenolic groups. 
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2.2.3.5 Synthesis of calix[4]arene-capped (3-(2-O-ß-cyclodextrin)-2- 
hydroxypropoxy)-propylsilyl-bonded silica particles (C[4]CD-HPS) 
 
Briefly, C[4]CD-HPS was synthesized by treatment of BACD-HPS with 
excess calix[4]arene in anhydrous NMP with the presence of K2CO3 under 
nitrogen (Thamarai et al., 2010). The scheme of synthesis is shown in Fig. 2.7. 
Calix[4]arene is proposed to attach the β-CD in BACD-HPS through the 
reaction of phenolic groups with bromoacetate of BACA-HPS via the single 
linkage due to steric constraints. Typically, 0.64 g of calix[4]arene (1.5 mmol), 
previously dried under vacuum at 80 °C for over 12 h, was dissolved in 50 mL 
of anhydrous NMP with 10 mg of K2CO3. Afterwards, 2 g of BACD-HPS 
(prepared from 5 μm silica), previously dried under vacuum at 60 °C for over 
12 h, was added into the reaction mixture which would be stirred continuously 
at 75 °C for 24 h. Finally, the product C[4]CD-HPS was filtered and washed 
successively with NMP, MeOH, water and acetone, then purified by Soxhlet 
extraction using acetone for 12 h. 
 
 
2.2.3.6 Synthesis of C-methylcalix[4]resorcinarene-capped (3-(2-O-ß- 
cyclodextrin)-2-hydroxypropoxy)-propylsilyl-bonded silica particles 
(MCRCD-HPS) 
 
Briefly, MC[4]RCD-HPS was synthesized by treatment of BACD-HPS with 
excess MCR in anhydrous NMP with the presence of K2CO3 under nitrogen. 
The scheme of synthesis is shown in Fig. 2.7. Similar to calix[4]arene, MCR is 
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proposed to attach the β-CD in BACD-HPS through the reaction of phenolic 
groups with bromoacetate in BACD-HPS. Typically, 0.82 g of MCR (1.5 
mmol), previously dried under vacuum at 80 °C for over 12 h, was dissolved 
in 50 mL of anhydrous NMP with 10 mg of K2CO3. Afterwards, 2 g of 
BACD-HPS (prepared from 5 μm silica), previously dried under vacuum at 
60 °C for over 12 h, was added into the reaction mixture which would be 
stirred continuously at 75 °C for 24 h. Finally, the product MCRCD-HPS was 
filtered and washed successively with NMP, MeOH, water and acetone, then 








































Calix[4]arene       NMP
BACD-HPS




Fig. 2.7. Synthesis of C[4]CD-HPS and MCRCD-HPS. 
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2.2.4 Synthesis of modified MCR-bonded silica particles  
         
2.2.4.1 Synthesis of (3-(C-methylcalix[4]resorcinarene)-2-hydroxypropoxy)- 
propylsilyl-bonded silica particles (MCR-HPS) 
 
Briefly, MCR-HPS was synthesized via a similar procedure to prepare 
CD-HPS, i.e. anchoring MCR onto silica particles in anhydrous NMP with the 
presence of GPS under nitrogen (Tan et al., 2011). The scheme of synthesis is 
shown in Fig. 2.8. Typically, 2.56 g of MCR (4.7 mmol), previously dried 
under vacuum at 80 °C for over 12 h, was dissolved in 100 mL of anhydrous 
NMP. Then, 0.2 g of 60% NaH (5 mmol) was added into the solution which 
would be stirred at room temperature until becoming clear. Next, 0.42 mL of 
GPS (1.9 mmol) was added and the mixture was stirred continuously at 70 °C 
for 4 h. ESI-MS was used to confirm the intermediate product   
(3-(C-methylcalix[4]resorcinarene)-2-hydroxypropoxy)-propylsilyl, MCR-HP. 
Afterwards, 5 g activated silica (3 μm or 5 μm), previously dried under 
vacuum at 120 °C for over 12 h, was added and the reaction was continued at 
70 °C, 80 °C, 90 °C, 100 °C for 1 h each and 110 °C for 20 h. Finally, the 
product MCR-HPS was filtered and washed successively with NMP, MeOH, 
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2.2.4.2 Synthesis of bromoacetate-substituted (3-(C-methylcalix[4]- 
resorcinarene)-2-hydroxypropoxy)-propylsilyl-bonded silica particles 
(BAMCR-HPS) 
 
Briefly, BAMCR-HPS was synthesized by treatment of MCR-HPS with 
excess bromoacetyl chloride in anhydrous DCM with the presence of AlCl3 
under nitrogen (Tan et al., 2011). The scheme of synthesis is shown in Fig. 2.9. 
Typically, 3 g of MCR-HPS (prepared from 3 or 5 μm silica), previously dried 
under vacuum at 60 °C for over 12 h, was added into 100 mL of anhydrous 
NMP with 0.3 g of AlCl3, which was stirred continuously in an ice bath. Then, 
0.67 mL of bromoacetyl chloride (8 mmol) in 67 mL of anhydrous DCM was 
added into the reaction mixture drop by drop for over 2 h. Afterwards, the 
reaction was continued for 40 h at room temperature. Finally, the product 
BMCR-HPS was filtered and washed successively with DCM, MeOH, water 










2.2.4.3 Synthesis of rifamycin-capped (3-(C-methylcalix[4]resorcinarene)-2- 
hydroxypropoxy)-propylsilyl-bonded silica particles (RMCR-HPS) 
 
Briefly, RMCR-HPS was synthesized by treatment of BAMCR-HPS with 
excess rifamycin SV in anhydrous ACN with the presence of K2CO3 under 
nitrogen. The scheme of synthesis is shown in Fig. 2.10. Similar to RCD-HPS, 
rifamycin is proposed to attach the MCR in BAMCR-HPS via the reaction of 
amido group with bromoacetate in BAMCR-HPS. Typically, 0.43 g of 
rifamycin SV sodium salt (0.6 mmol), previously dried under vacuum at 80 °C 
for over 12 h, was dissolved in 100 mL anhydrous ACN with 10 mg of K2CO3. 
Afterwards, 2 g of BAMCR-HPS (prepared from 3 or 5 μm silica), previously 
dried under vacuum at 60 °C for over 12 h, was added into the reaction 
mixture which would be stirred continuously and refluxed (around 82 °C) for 
24 h. Finally, the product RMCR-HPS was filtered and washed successively 
with ACN, MeOH, water and acetone, then purified by Soxhlet extraction 
using acetone for 12 h.  
 
 
2.2.4.4 Synthesis of 1-aza-15-crown-5-capped (3-(C-methylcalix[4]- 
resorcinarene)-2-hydroxypropoxy)-propylsilyl-bonded silica particles 
(15C5-MCR-HPS) 
 
Briefly, 15C5MCR-HPS was synthesized by treatment of BAMCR-HPS with 
excess 15C5 in anhydrous ACN with the presence of K2CO3 under nitrogen. 
The scheme of synthesis is shown in Fig. 2.10. Since 15C5 molecule has only 
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one second amine group (–NH–) which is more reactive than other functional 
groups, 15C5 is proposed to attach the MCR in BAMCR-HPS via the reaction 
of amine group with bromoacetate in BAMCR-HPS. Typically, 0.22 g of 15C5 
(1 mmol), previously dried under vacuum at 80 °C for over 12 h, was 
dissolved in 100 mL of anhydrous ACN with 10 mg of K2CO3. Afterwards, 2 g 
of MCR-HPS (prepared from 3 μm silica), previously dried under vacuum at 
60 °C for over 12 h, was added into the reaction mixture which would be 
stirred continuously and refluxed (around 82 °C) for 24 h. Finally, the product 
15C5MCR-HPS was filtered and washed successively with ACN, MeOH, 






















































































Fig. 2.10. Synthesis of 15C5-MCR-HPS and RMCR-HPS. 
 47 
2.3 Results and discussion 
 
A series of characterization analysis including SEM/EDS, ESI-MS, elemental 
analysis and FRIT were undertaken to confirm the structure of synthesized 
novel bonded silica particles.  
 
 
2.3.1 SEM/EDS analysis 
 
Typical SEM/EDS results of silica (3 µm), BACD-HPS (based on 5 µm silica) 
and MCR-HPS (based on 3 µm silica) are shown in Fig. 2.11~2.13. The SEM 
images indicate the diameter of each (bonded) silica particle. The variations of 
diameter for all silica particles are all located at acceptable range for stationary 
phases, especially the 3 µm silica particles in a narrow ditribution range. 
Theoretically, the diameter of stationary phase particles with smaller variation 
will lead to lower Eddy-diffusion and therefore higher column efficiency in 
chromatography. Thus, the novel bonded silica particles based on 3 µm silica 
may achieve better separation perfermance in chromatography than 5µm 
silica. In addition, EDS result proves the successful synthesis of novel bonded 
silica particles due to the presence of carbon and oxygen peaks which are from 
















Fig. 2.13. SEM/EDS analysis of MCR-HPS based on 3 µm silica. (Top) 
SEM image, (Bottom) EDS analysis. 
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2.3.2 Mass spectrometry analysis 
 
In order to confirm the structures of novel MCR-based CSPs, especially the 
starting material MCR-HPS, intermediate product of the reaction between 
GPS and MCR (via the substitution of NaH) was confirmed by MS. The 
on-line reaction sample was taken during reaction before adding silica (refer to 
Section 2.2.4.1) and dilute by MeOH to 1 μg/mL (MCR concentration) for MS 
analysis. Based on the ESI-MS spectrum in positive mode as shown in Fig. 
2.14, a clear [M+H]+ peak of m/z 781 matches the molecular formula of 
C41H52O13Si for MCR-HP, the intermediate product for MCR-HPS synthesis 










550 600 650 700 750 m/z
 
 
Fig. 2.14. Mass spectrum of MCR-HP ion in positive ESI mode. 
 
        Sample concentration: MCR in MeOH at 1 μg/mL. 
 
 
2.3.3 Elemental analysis 
 
The elemental analysis results of different boned silica particles are list in 
Table 2.1. The increasing carbon and hydrogen content between the starting 
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materials and products in each step, e.g., CD-HPS and BACD-HPS, indicates 
that new recognition sites were successfully introduced to the bonded silica 
particles as expected. 
 
Table 2.1. Elemental analysis of different novel bonded silica particles. 
 






CD-HPS 6.91 1.41 
BACD-HPS 8.01 1.47 
RCD-HPS 12.42 2.73 
VCD-HPS 11.91 2.18 
C[4]CD-HPS 8.97 2.01 
   
MCR-HPS 4.02 1.04 
BAMCR-HPS 4.35 1.06 
RMCR-HPS 5.15 1.32 
15C5-MCR-HPS 5.21 1.25 
 
 
2.3.4 Fourier-transform infrared spectroscopy analysis 
 
Typical FTIR spectrums of bonded silica particles VCD-HPS, RCD-HPS, 



















All bonded silica particles exhibit the absorptions at 3400~3600 cm−1 for 
silanol stretching of silica, the absorptions at 3200~3400 cm−1 for aromatic 
C-H bending, the absorptions at 2850~2950 cm−1 for aliphatic C-H stretching 
and the absorptions at 1500~1550 cm−1 for aromatic C=C bending. For 
VCD-HPS, the absorptions at 1750cm−1 indicates C=O stretching frequency 
for vancomycin moiety. For BAMCR-HPS, the absorptions at 3000cm−1 





A series of novel antibiotic-capped β-CD/MCR-bonded silica particles were 
successfully synthesized. Briefly, ß-CD was anchored onto silica to synthesize 
CD-HPS which was derivatized by treatment with bromoacetyl bromide to 
form BACD-HPS. The second recognition moiety was then attached by 
treatment of BACD-HPS with vancomycin, rifamycin, calix[4]arene or MCR. 
Similarly, MCR was anchored onto silica to synthesize MCR-HPS which was 
derivatized by treatment with bromoacetyl chloride to form BAMCR-HPS. 
The second recognition moiety was later attached by treatment of 
BAMCR-HPS with rifamycin or 15C5. All novel bonded silica particles were 
characterized qualitatively and quantitatively by a series of instrumental 










APPLICATION OF VCD-HPS AND RCD-HPS AS 





The success of macrocyclic antibiotics as chiral selector in LC (refer to 
Section 2.1.3) indicates to use antibiotic cooperating with β-CD for novel 
CSPs development. In this chapter, two novel antibiotic-caped β-CD-bonded 
silica particles, VCD-HPS and RCD-HPS, are introduced as CSPs in HPLC 
for enantioseparation. Their enantioselectivity in HPLC were investigated 
under different mobile phase conditions. In addition, the enantioseparation 





3.2.1 Reagents and materials 
 
The reagents and starting materials were purchased from commercial 





An Agilent Technologies (Waldbronn, Germany) Model1100 system equipped 
with binary pump, auto sampler and multiple wave-length UV detector was 
used for chromatographic separation. Chemstation software (Rev.A.09.03) 
was used to record and process all chromatographic data. 
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3.2.3 Preparation of stationary phase materials 
 
The bonded silica particles VCD-HPS and RCD-HPS were prepared via the 
successive multiple step liquid-solid phase reaction (refer to Section 2.2.3.3 
and Section 2.2.3.4) as reported (Zhao et al., 2010a, b). Briefly, BACD-HPS 
was reacted with excess vancomycin to form VCD-HPS (refer to Section 
2.2.3.4). Similarly, RCD-HPS were prepared by treating BACD-HPS with 
rifamycin SV (refer to Section 2.2.3.4). 
 
 
3.2.4 Preparation of novel CSP-packed HPLC columns 
 
Up to now, only few labs develop own facilities for packing LC columns while 
most labs rely on commercial manufacturers to provide the columns required. 
Except the labs involved in design of new stationary phases, most advances of 
column packing technique occurred in commercial sectors and this knowledge 
is commonly treated as proprietary information (Poole, 2003).  
 
Although acceptable columns can be prepared by using a variety of different 
procedures, there is limited success achieved for the attempts to optimize 
variables and identify the best methods (Stanley, 1997). Generally, the 
difficulty of preparing column with satisfied chromatographic performance 
rises with decreasing particle size, decreasing column diameter, increasing 
column length, and independent of packing technique. Choosing proper 
column packing method mainly depends on the mechanical strength, particle 
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size and surface properties of packing materials. Dry packing method is 
competent for packing particles large than 20 μm (in average diameter). By 
contrast, high-pressure slurry packing method is suitable for packing smaller 
particles. 
 
For slurry packing method, the critical steps are slurry preparation, filtration of 
slurry through the column to form particle bed, compaction and conditioning 
of particle bed. Meanwhile, the packing particles have to enter column at high 
velocity in order to overcome frictional forces from viscous flow around the 
particles and interior wall of column. Moreover, packing speed is dependent 
on the applied pressure, slurry viscosity and particle size. Therefore, slurry 
liquid with higher pressure and lower viscosity is more favorable for packing 
smaller particles in 2~5 μm (Verzele, 1987). In addition, conventional 
analytical columns are mainly packed by constant pressure packing technique. 
 
The empty column must be able to withstand high pressure used for column 
packing and normal operation, and chemically resistant to different kinds of 
mobile phases. For most applications, seamless and polished 316 stainless 
steel is the preferred material to meet such requirements. The packing material 
is retained and protected from intrusion of particle matter by sintered metal or 
porous polymer frits, which are usually inserted into column ends with pore 
diameter less than the packing particle size. Typical HPLC column parts and 
packing device are illustrated in Fig.3.1. 
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Fig. 3.1. Typical HPLC column parts and packing device set-up. 
 
The detailed packing procedures of HPLC columns used for this dissertation 
are as following. Firstly, 0.5 g packing material (bonded silica particles) was 
suspended in the slurry solvent, mixture of 1.5 mL chloroform and 3 mL 
1,4-dioxane, then degassed and dispersed under ultrasonic bath. Meanwhile, 
the outlet end of packing chamber (slurry reservoir) was connected to the top 
end of empty column, which bottom end was assembled with ending fritting 
tightly. The whole packing devices were positioned vertically. Thereafter, 
suspended slurry was transferred to the packing chamber while packing 
solvent (40 mL MeOH) was filled to cover the slurry. Afterwards, the inlet end 
of packing chamber was connected to packing pump. Subsequently, the slurry 
was transferred by packing solvent to the empty column at constant flow rate 
(1 Ml/min) until the backpressure increased to 350 bar (limit pressure). The 
packing was continued while the backpressure was kept at 350 bar till all 
slurry solvent passing through the column, and then gradually reduced at 1 
bar/min until reaching atmospheric pressure. Finally, packing device was 
detached and packing column was completely assembled by fixing another 
ending fritting at the top end.  
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3.2.5 Chromatographic procedures 
 
The synthesized bonded silica particles VCD-HPS and RCD-HPS were packed 
into 150 mm × 2.0 mm I.D. stainless steel columns (Phenomenex, Torrance, 
CA, USA) by the modified slurry method (refer to Section 3.2.4). The packed 
HPLC columns were preconditioned by each mobile phase for at least 1 h 
before chromatographic application. The teiethylamine-acetate (TEAA) buffer 
was prepared by dissolving desired amount of pure TEA in water to achieve 
1% concentration and then adding acetic acid to achieve required pH. The 
mixtures of MeOH/H2O, ACN/H2O and ACN/TEAA buffer solutions with 
different volume ratios were used as mobile phases, which were degassed by 
sonication for at least 45 min before use. All samples were prepared by 
dissolving in MeOH or ACN at the concentrations of 0.5~5 mmol/L and then 
degassed by sonication for at least 10 min before injection. The injection 
volume of each analysis was 5~10 μl while HPLC was carried out at room 
temperature. The baseline perturbations caused by the injection of mobile 
phase were used as void volume marker (t0) for separation data analysis. All 
separations were monitored at different UV wavelengths (210nm, 230nm, 
254nm and 280nm). The reported chromatographic data in this chapter were 




3.3 Results and discussion 
 
3.3.1 Evaluation of VCD-HPS and RCD-HPS by disubstituted benzenes 
 
The chromatographic performance of VCD-HPS and RCD-HPS was 
investigated by using MeOH/H2O mixtures as mobile phases and the 
positional isomers of disubstituted benzenes (i.e. o-, m-, p-nitrophenol and 
nitroaniline) as solutes. The influence of MeOH content in mobile phase on 
retention behavior of solutes are compared and shown in Table 3.1 (Thamara 
ea al., 2010; Zhao et al., 2010a, b). Briefly, the retention factor (k) of all 
solutes on both VCD-HPS and RCD-HPS packed columns are increased as the 
MeOH content decreased, which indicates these two stationary phases may 
have hydrophobic interaction with solutes. 
 
The positional isomers of disubstituted benzenes are commonly utilized to 
evaluate the stationary phases in LC (Liu, 2005). In this study, baseline 
separations of all positional isomers of nitrophenols and nitroanilines were 
achieved on both VCD-HPS and RCD-HPS packed columns. Typical 
chromatograms depicting the separation of isomers of o-, m-, p-nitrophenol are 
shown in Fig.3.2.  
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Table 3.1. Retention factors (k) for positional isomers of nitroaniline and 
nitrophenol on BACD-HPS, VCD-HPS and RCD-HPS packed 
HPLC columns under vaired MeOH/H2O proportions.  
 
Solutes 
MeOH : H2O (v/v) 
CSP 
100:0 80:20 60:40 40:60 20:80 
o-Nitroaniline 
0.3 0.5 1.2 3.4 7.9 BACD-HPS 
0.8 0.9 1.4 2.8 8.2 VCD-HPS 
0.2 0.3 0.4 0.8 2.1 RCD-HPS 
       
m-Nitroaniline 
0.3 0.5 1.2 3.3 6.3 BACD-HPS 
0.8 1.0 1.3 2.6 6.7 VCD-HPS 
0.2 0.3 0.4 0.7 1.6 RCD-HPS 
       
p-Nitroaniline 
0.6 0.7 3.0 3.6 19.4 BACD-HPS 
1.1 1.5 2.0 5.8 17.0 VCD-HPS 
0.3 0.5 0.6 1.8 4.8 RCD-HPS 
       
o-Nitrophenol  
0.4 0.5 2.5 2.6 3.4 BACD-HPS 
0.8 0.9 1.5 3.1 7.3 VCD-HPS 
0.2 0.3 0.3 0.7 1.8 RCD-HPS 
       
m-Nitrophenol 
0.2 0.3 0.9 1.2 2.3 BACD-HPS 
0.7 0.8 1.2 3.2 8.4 VCD-HPS 
0.2 0.3 0.4 0.9 2.5 RCD-HPS 
       
p-Nitrophenol 
0.6 1.1 6.4 10.1 15.2 BACD-HPS 
1.0 1.2 2.6 7.4 16.1 VCD-HPS 
0.3 0.4 0.5 1.4 3.6 RCD-HPS 
 
BACD-HPS packed column at 250 mm × 4.6 mm (I.D.); VCD-HPS and 


















































Fig. 3.2. Chromatograms for separation of o-, m-, p-nitrophenol on   
BACD-HPS, VCD-HPS and RCD-HPS packed HPLC columns 





Interestingly, the elution order of nitrophenol isomers on VCD-HPS packed 
column is m < o < p as MeOH content decreased from 100 to 60% in mobile 
phases, but it changed to o < m < p after MeOH content reduced to 40% or less 
in mobile phases.  
 
As shown in Fig. 3.2, the elution order of nitrophenol isomers on both 
VCD-HPS and RCD-HPS packed columns is o < m < p different from m < o < 
p on BACD-HPS packed column using MeOH/H2O (20:80, v/v) as mobile 
phase. Nevertheless, the elution order is p < m < o on octadecyl packed 
column under same condition (Liu, 2005). These differences indicate that both 
vancomycin and rifamycin SV make contribution for separation with extra 
interactions like hydrogen bonding and п-п interactions after introduced into 
the new CSPs. 
 
 
3.3.2 Enantioseparation on VCD-HPS in HPLC 
 
The chromatographic performance of VCD-HPS packed HPLC column for 
enantioseparation of chiral compounds was studied under reversed-phase 
chromatography mode with varied mobile phase conditions. 
 
The progress of enantioseparation of indapamide with varied MeOH/H2O 
proportions is shown in Table 3.2 and Fig. 3.3. Briefly, higher 
enantioselectivity, higher resolution with longer retention time were achieved 
as water content increased. Baseline enantioseparation could be obtained after  
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MeOH content decreased to 20% or less. It is suggested that the main chiral 
recognition mechanism for VCD-HPS is to form inclusion complex that 
hydrophobic portion of solute is included in ß-CD cavity, and vancomycin 
provides further interactions like hydrogen bonding and п-п interactions with 
solute (Zhao et al., 2010b).  
 
Table 3.2. Progressive enantioseparation of indapamide on VCD-HPS 
packed HPLC column under varied MeOH/H2O proportions. 
 
 
t1: retention time of the first enaniomer eluted out; k1: retention factor of the 




t1 k1 α Rs 
 
MeOH/H2O (40:60, v/v) 13.1 2.8 1.1 0.9 
MeOH/H2O (20:80, v/v) 32.5 9.8 1.2 1.0 




               MeOH/H2O   
(40:60, v/v) 
 



























               MeOH/H2O  
(10:90, v/v) 
 











Fig. 3.2. Chromatograms for progressive enantioseparation of indapamide 
on VCD-HPS packed HPLC column under varied MeOH/H2O 
proportions. 
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Meanwhile, a wide range of chiral compounds were resolved on the 
VCD-HPS packed HPLC column under different mobile phase conditions. 
Table 3.4 lists the best separation data for each chiral compound with the 
mobile phase employed. Typical chromatograms of enantioseparations on 
VCD-HPS packed column are shown in Fig. 3.3~ 3.5.  
 
Table 3.3. Typical enantioseparation data of chiral compounds on 
VCD-HPS packed HPLC column. 
 
 
k1: retention factor of the first enantiomer eluted out; α: enantioselectivity; Rs: 























0.5 2.2 1.9 
Methyl mandelate MeOH/H2O 
(20:80, v/v) 
1.1 2.4 3.7 
1-Phenyl-1-propanol MeOH/H2O 
(20:80, v/v) 





3.4 1.4 1.1 
Ibuprofen ACN/H2O 
(80:20, v/v) 
1.8 1.1 0.5 
Proglumide ACN/TEAA, pH = 4 
(10:90, v/v) 
3.4 1.4 2.3 
Labetalol ACN/TEAA, pH = 4 
(10:90, v/v) 
1.4 1.2 0.4 
Warfarin ACN/TEAA, pH = 4 
(10:90, v/v) 
17.4 1.3 1.8 
α-Methylbenzylamine ACN/TEAA, pH = 7 
(10:90, v/v) 
1.4 2.6 3.3 
Metoprolol ACN/TEAA, pH = 7 
(10:90, v/v) 
4.2 1.2 0.7 
Pindolol ACN/TEAA, pH = 7 
(10:90, v/v) 




          1-phenyl-1-propanol 
 













Fig. 3.4. Chromatogram for enantioseparation of 1-phenyl-1-propanol on 
VCD-HPS packed HPLC column.  
 
Conditions: 150 mm × 2.0 mm (I.D.) column,  




          Proglumide 
 














Fig. 3.5. Chromatogram for enantioseparation of proglumide on 
VCD-HPS packed HPLC column.  
 
Conditions: 150 mm × 2.0 mm (I.D.) column,  






        














Fig. 3.6. Chromatogram for enantioseparation of pindolol on VCD-HPS 
packed HPLC column.  
 
Conditions: 150 mm × 2.0 mm (I.D.) column,  
ACN/TEAA, pH = 7 (10:90, v/v) as mobile phase. 
 
Compared to the BACD-HPS packed HPLC column previously reported by 
our group (Thamarai et al., 2010), better enantioselectivity and higher 
resolution were achieved on VCD-HPS packed column for a broad range of 
chiral compounds including (1S,2R)-2-amino-1,2-diphenylethanol (no 
separation on BACD-HPS versus α = 1.4 and Rs = 1.1 on VCD-HPS), 
indapamide (no separation on BACD-HPS versus α = 1.3 and Rs = 1.2 on 
VCD-HPS), methyl mandelate (α = 1.6 and Rs = 1.5 on BACD-HPS versus α 
= 2.4 and Rs = 3.7 on VCD-HPS), α-methylbenzylamine (α = 2.5 and Rs = 2.5 
on BACD-HPS versus α = 2.6 and Rs = 3.3 on VCD-HPS), metoprolol (no 
separation on BACD-HPS versus α = 1.2 and Rs = 0.7 on VCD-HPS), 
1-phenyl-1-propanol (α = 1.4 and Rs = 1.4 on BACD-HPS versus α = 1.6 and 
Rs = 3.2 on VCD-HPS), phenylalanine (α = 2.0 and Rs = 1.7 on BACD-HPS 
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versus α = 2.2 and Rs = 1.9 on VCD-HPS) and pindolol (no separation on 
BACD-HPS versus α = 2.0 and Rs = 3.0 on VCD-HPS) under similar mobile 
phase conditions. In addition, there was also significant improvement in chiral 
resolution for some chiral compounds like proglumide (Rs = 0.4 on 
BACD-HPS versus Rs = 2.3 on VCD-HPS) and warfarin (Rs = 0.9 on 
BACD-HPS versus Rs = 1.8 on VCD-HPS) under similar mobile phase 
conditions. These results indicate that vancomycin plays an important role in 
VCD-HPS to improve chiral recognition for higher coverage of chiral 
compounds, and also indirectly prove the successful synthesis of VCD-HPS. 
 
Compared to the commercial ß-CD-based CSP (Cyclobond I) column (Chang 
et al., 1993), better enantioselectivity (with higher resolution) was achieved on 
VCD-HPS packed column for pindolol (α = 1.1 and Rs = 1.7 on Cyclobond I 
versus α = 2.0 and Rs = 3.0 on VCD-HPS), proglumide (α = 1.3 on Cyclobond 
I versus α = 1.4 on VCD-HPS) and warfarin (α = 1.2 and Rs = 1.6 on 
Cyclobond I versus α = 1.3 and Rs = 1.8 on VCD-HPS) under similar mobile 
phase conditions. Compared to commercial vancomycin-based CSP 
(Chirobiotic V) column (Armstrong et al., 1994), better enantioselectivity was 
achieved on VCD-HPS packed column for indapamide (α = 1.1 on Chirobiotic 
V versus α = 1.3 on VCD-HPS) under similar mobile phase condition. In 
addition, the Chirobiotic V was reported without enantioselectivity to amino 
acid (Staroverov, 2006), nevertheless, baseline separation of phenylalanine (α 
= 2.2 and Rs = 1.9) was easily achieved on the VCD-HPS packed column. 
These improvements are conceivably due to the cooperative function of ß-CD 
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and vancomycin in VCD-HPS which enhances the host-guest interaction with 
solute resulting in improved chiral recognition and enantioselectivity for 
higher coverage of chiral compounds. 
 
Compared to the AQ2D18C6-CD-HPS (diaza-18-crown-6-capped 
ß-CD-bonded silica) packed column previously reported by our group (Gong 
et al., 2003a), better enantioselectivity (with higher resolution) was achieved 
on VCD-HPS packed column for a broad range of chiral compounds including 
indapamide (α = 1.1 on AQ2D18C6-CD-HPS versus α = 1.2 on VCD-HPS), 
pindolol (no separation on AQ2D18C6-CD-HPS versus α = 2.0 and Rs = 3.0 
on VCD-HPS) and phenylalanine (no separation on AQ2D18C6-CD-HPS 
versus α = 2.2 and Rs = 1.9 on VCD-HPS). These results suggest that 
vancomycin is better than crown ethers as the second chiral recognition site 
capped on CD-HPS for enantioseparation of the chiral compounds mentioned. 
 
 
3.3.3 Enantioseparation on RCD-HPS in HPLC 
 
The chromatographic performance of RCD-HPS packed HPLC column for 
enantioseparation of chiral compounds was studied under reversed-phase 
chromatography mode with varied mobile phase condtitions. 
 
The progress of enantioseparation of 1-phenyl-1-propanol with varied 
MeOH/H2O proportions is shown in Table 3.4 and Fig. 3.7. Briefly, higher 
enantioselectivity, higher resolution with longer retention time were achieved 
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as water content increased. Baseline enantioseparation could be obtained after 
MeOH content decreased to 20% or less. It is suggested that the main chiral 
recognition mechanism for RCD-HPS is to form inclusion complex that 
hydrophobic portion of solute is included in ß-CD cavity, and rifamycin 
provides further interactions like hydrogen bonding and п-п interactions with 
the solute (Zhao et al., 2010a). 
 
Meanwhile, a wide range of chiral compounds were resolved on the RCD-HPS 
packed HPLC column under different mobile phase conditions. Table 3.5 lists 
the best separation data for each chiral compound with the mobile phase 
employed. Typical chromatograms of enantioseparations on RCD-HPS packed 
column are shown in Fig. 3.8~ 3.11. 
 
Table 3.4. Progressive enantioseparation of 1-phenyl-1-propanol on 




t1: retention time of the first enaniomer eluted out; k1: retention factor of the 




t1 k1 α Rs 
 
MeOH/H2O (40:60, v/v) 5.5 0.3 1.2 0.6 
MeOH/H2O (20:80, v/v) 6.9 1.0 1.6 1.6 




             MeOH/H2O 
(40:60, v/v) 
 












            MeOH/H2O  
(80:20, v/v) 
 












            MeOH/H2O  
(5:95, v/v) 
 











Fig. 3.7. Chromatograms for progressive enantioseparation of 
1-phenyl-1-propanol on RCD-HPS packed HPLC column 
under varied MeOH/H2O proportions.  
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Table 3.5. Typical enantioseparation data of chiral compounds on 
RCD-HPS packed HPLC column. 
 
 
k1: retention factor for the first enantiomer eluted out; α: enantioselectivity;  





















2.0 1.9 2.7 
Indapamide MeOH/H2O 
(10:90, v/v) 
3.0 1.2 1.1 
Warfarin MeOH/H2O 
(20:80, v/v) 
5.7 1.3 1.2 
Labetalol MeOH/H2O 
(40:60, v/v) 
1.5 1.1 1.0 
Propanolol MeOH/H2O 
(40:60, v/v) 
1.2 1.2 0.9 
Tyrosine MeOH/H2O 
(40:60, v/v) 
0.2 2.5 1.3 
Metoprolol ACN/H2O 
(20:80, v/v) 
0.8 2.0 1.2 
(1S,2R)-2-Amino-1,2- 
diphenylethanol 
ACN/TEAA, pH = 4 
(10:90 v/v) 
0.3 2.5 2.5 
Benzyl mandelate ACN/TEAA, pH = 4 
(10:90, v/v) 
2.1 1.2 0.7 
Dichloroprop ACN/TEAA, pH = 7 
(5:95, v/v) 
0.7 1.6 1.5 
α-Methylbenzylamine ACN/TEAA, pH = 7 
(5:95, v/v) 
0.4 3.5 3.7 
Proglumide ACN/TEAA, pH = 7 
(5:95,v/v) 
0.7 1.4 1.0 
Indoprofen ACN/TEAA, pH = 7 
(10:90, v/v) 
1.3 1.2 1.1 
Ketoprofen ACN/TEAA, pH = 7 
(10:90, v/v) 
1.4 1.1 0.8 
Pindolol ACN/TEAA, pH = 7 
(10:90, v/v) 




          Warfarin 
 














Fig. 3.8. Chromatogram for enantioseparation of warfarin on RCD-HPS 
packed HPLC column.  
 
Conditions: 150 mm × 2.0 mm (I.D.) column,  





          α-methylbenzylamine 
 













Fig. 3.9. Chromatogram for enantioseparation of α-methylbenzylamine on 
RCD-HPS packed HPLC column. 
 
Conditions: 150 mm × 2.0 mm (I.D.) column,  





          Dichloroprop 
 













Fig. 3.10. Chromatogram for enantioseparation of dichloroprop on 
RCD-HPS packed HPLC column. 
  





          Pindolol 
 














Fig. 3.11. Chromatogram for enantioseparation of pindolol on RCD-HPS 
packed HPLC column. 
 
 Conditions: 150 mm × 2.0 mm (I.D.) column,  
 ACN/TEAA, pH = 7 (10:90, v/v) as mobile phase 
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Compared to the BACD-HPS packed column previously reported by our 
group (Thamarai et al., 2010), better enantioselectivity and higher resolution 
were achieved on RCD-HPS packed column for a broad range of chiral 
compounds including (1S,2R)-2-amino-1,2-diphenylethanol (no separation on 
BACD-HPS versus α = 2.5 and Rs = 2.5 on RCD-HPS), indapamide (no 
separation on BACD-HPS versus α = 1.2 and Rs = 1.1 on RCD-HPS), 
ketoprofen (no separation on BACD-HPS versus α = 1.1 and Rs = 0.8 on 
RCD-HPS), labetalol (no separation on BACD-HPS versus α = 1.1 and Rs = 
1.0 on RCD-HPS), α-methylbenzylamine (α = 2.5 and Rs = 2.5 on 
BACD-HPS versus α = 3.5 and Rs = 3.7 on RCD-HPS), 1-phenyl-1-propanol 
(α = 1.4 and Rs = 1.4 on BACD-HPS versus α = 1.9 and Rs = 2.7 on 
RCD-HPS), propanolol (no separation on BACD-HPS versus α = 1.2 and Rs = 
0.9 on VCD-HPS) and pindolol (no separation on BACD-HPS versus α = 1.7 
and Rs = 1.8 on RCD-HPS) under similar mobile phase conditions. In addition, 
there was also significant improvement in chiral resolution for some chiral 
compounds like dichloroprop (Rs = 0.9 on BACD-HPS versus Rs = 1.5 on 
VCD-HPS), 1-(1-naphthyl)ethanol (Rs = 1.2 on BACD-HPS versus Rs = 1.3 
on RCD-HPS), proglumide (Rs = 0.4 on BACD-HPS versus Rs = 1.0 on 
RCD-HPS) and warfarin (Rs = 0.9 on BACD-HPS versus Rs = 1.2 on 
RCD-HPS). These results indicate that rifamycin plays an important role in 
RCD-HPS to improve chiral recognition for higher coverage of chiral 
compounds, and also indirectly prove the successful synthesis of RCD-HPS. 
 
Compared to commercial ß-CD-based CSP (Cyclobond I) column (Berthod et 
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al., 1990; Chang et al., 1993), better enantioselectivity (with higher resolution) 
was achieved on RCD-HPS packed column for metoprolol (α = 1.0 and Rs = 
0.9 on Cyclobond I versus α = 2.0 and Rs = 1.2 on RCD-HPS), pindolol (α = 
1.1 and Rs = 1.7 on Cyclobond I versus α = 1.7 and Rs = 1.8 on RCD-HPS),  
proglumide (α = 1.3 on Cyclobond I versus α = 1.4 on RCD-HPS) and 
propanolol (α = 1.1 on Cyclobond I versus α = 1.2 on RCD-HPS) under 
similar mobile phase conditions. Similar to VCD-HPS, these improvements 
are conceivably due to the cooperative function of ß-CD and rifamycin in 
RCD-HPS which enhances the host-guest interaction with solute to improve 
chiral recognition and enantioselectivity for higher coverage of chiral 
compounds. 
 
Compared to the AQ2D18C6-CD-HPS (diaza-18-crown-6-capped 
ß-CD-bonded silica) packed column previously reported by our group (Gong 
et al., 2003a), better enantioselectivity was achieved on RVCD-HPS packed 
column for a broad range of chiral compounds including indapamide (α = 1.1 
on AQ2D18C6-CD-HPS versus α = 1.2 on RCD-HPS), pindolol (no 
separation on AQ2D18C6-CD-HPS versus α = 1.7 and Rs = 1.8 on RCD-HPS) 
and propanolol (α = 1.1 on AQ2D18C6-CD-HPS versus α = 1.2 on 
RCD-HPS). These results suggest that rifamycin is better than crown ethers as 
the second chiral recognition site capped on CD-HPS for enantioseparation of 






Two novel antibiotic-capped β-CD-bonded silica particles, VCD-HPS and 
RCD-HPS, were successfully applied as CSPs in HPLC to separate aromatic 
positional isomers and chiral compounds. Their chromatographic performance 
suggests they are of notalbe advantages and potential for enantioseparation for 
a wide range of chiral drugs. Meanwhile, there is not significant change in the 
chromatographic performance of VCD-HPS and RCD-HPS packed HPLC 
columns observed after continuous usage over half year, especially under the 
mobile phase conditions containing TEAA buffer, which indicate both CSPs 










APPLICATION OF C[4]CD-HPS AND MCRCD-HPS 





Capillary electrochromatography (CEC, also called capillary electrokinetic 
chromatography) is a relative new "hybrid" liquid phase analytical separation 
technique. It combines the advantages of high chromatographic selectivity 
from HPLC and high separation efficiency with electromobility from CE. The 
separation in CEC is typically carrying out in a capillary column by 
electroosmotically-driven mobile phase under electric field. In CEC, the 
stationary phase packed in capillary column is used as in HPLC to separate 
interested components, while the mobile phase is transported through capillary 
column by the electroosmotic flow (EOF) which is generated by applying 
high-voltage to the electrolyte-filled capillary column. The landmarks in the 
history of CEC are listed in Table 4.1 (Bartle and Myers, 2001). 
 
Table 4.1. Significant landmarks in the evolution of CEC. 
 
Year Associated Development 
1939 EOF used in chromatography 
1954 EOF used in separation of polysaccharides 
1974 EOF used in column chromatography 
1981 Electroosmosis used in capillary 
1987 Paper chromatography introduced 
1991 Development of theory and technique of CEC  
1994 Analysis of pharmaceutical compounds by CEC 
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The flow profile of EOF is flat as shown in Fig. 4.1 which is different from the 
rounded laminar characteristic of pressure-driven flow in traditional 
chromatography columns. Since EOF is independent of conduit size and does 
not significantly contribute to band broadening, CEC is able to use stationary 
phase in smaller particles size which will enhance separation efficiency. 
Therefore, application of novel CSPs with high enantioselectivity in CEC is 
potential for fast enantioseparation with high resolution. 
 
 
Fig. 4.1. Flow profiles of pressure-driven flow and EOF. 
 
However, theoretical understanding of EOF and the associated transport 
phenomena in porous media especially CEC column is still an unsolved and 
complicated task (Deyl and Švec, 2001). Generally, neutral solute in CEC is 
separated by partitioning between mobile phase and stationary phases similar 
to HPLC. The charged solute, which has additional electrophoretic mobility in 
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the applied electric field of CEC, is separated by the combined effects of 
portioning and electrophoresis (Gong and Lee, 2003). 
 
As in every chromatographic system, capillary column is the key component 
in CEC to work as separation channel to transport mobile phase. Thus, 
preparation of capillary column is critical for CEC set-up and operation. Based 
on the existing state of column technology with wide application, CEC is 
mainly divided into two modes, open-tubular CEC and packed-column CEC. 
For open-tubular CEC, the stationary phase is typically coated and 
subsequently immobilized on the inner surface of capillary. The column could 
be prepared by either static coating (similar to GC column preparation) or 
chemical adsorption. Nowadays, the packed capillary column is dominant in 
CEC application. This kind column is mainly prepared from fused-silica 
capillary in 50~100 µm I.D. and packed with 3~5 µm packing material held in 
place with sintered retaining frits. The stationary phase particles are introduced 
into capillary column either by a pneumatic pump or other forces, then 
retained by the frits which are usually fabricated by in situ sintering. The 




Fig. 4.2. Schematic diagram of packed CEC column. 
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Currently, CEC separation is easily performed in the standard CE 
instrumentation. One obligatory modification of commercial CE equipment is 
the pressurization of running buffer in solvent vials. This technique can be 
classified into two modes. The first one is to apply gradient hydraulic pressure 
which is sufficiently high (more than 50 bar) to cause an additional pressure 
driven flow. The second one is an equal pressurization of both inlet and outlet 
vials with an inert gas at relative low pressure (less than 12 bar).  
 
The isocratic mode of CEC separations is particularly achieved by applying 
nitrogen gas on both inlet and outlet vials under the pressure of 2~12 bar. 
Column thermostating in CEC is regarded mandatory to avoid excessive radial 
temperature gradients within capillary. In addition, the analyte is typically 
injected electrokinetically and alternatively by applying external gas pressure 
into sample vial. Detection occurs directly through a non-packed section of 
capillary closed to the end of stationary phase. 
 
Up to now, there is no satisfactory explanation of the reason of bubble 
formation in packed-column CEC. It is proposed that bubbles are formed due 
to the differences in EOF velocity, i.e. between unpacked and packed sections 
of capillary (Horváth and Rathore, 1998), the differences in field strength or 
release of gas trapped in the pores or electrochemically formed (Carney et al., 
1999). Once bubbles formed, the detector baseline becomes very noisy with 
unstable current. This may result in the breakdown of current and even the 
stop of EOF. It is a general consensus that pressurization at inlet and/or outlet 
ends of column will prevent the bubble formation in packed CEC column. In 
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addition, performing reproducible CEC requires stringent control of 
parameters such as temperature, voltage and pressure. In commercial CE 
equipment, many of these parameters are automatically controlled which lead 
to significant improvements in reproducibility and accuracy of separation. 
 
Calixarene molecule has several phenolic hydroxyl groups which can be 
ionized to become negatively-charged and provide high EOF in CEC. This 
suggests to apply novel CSPs containing calixarene in CEC may achieve fast 
enantioseparation. In this chapter, two novel calixarene-caped β-CD-bonded 
silica particles, C[4]CD-HPS and MCRCD-HPS, are introduced as CSPs in 
CEC for enantioseparation. These CSPs have two recognition sites, calixarene 
and β-CD. Their enantioselectivity in CEC was investigated under different 
mobile phase conditions. In addition, their enantioseparation performance 





4.2.1 Reagents and materials 
 
The Tris-HCl buffer was prepared by adding concentrated hydrochloric acid to 
10 mM Tris solution to achieve the required pH. The rest reagents and starting 
materials were purchased from commercial resources and treated as standard 





An Agilent 3D-CE system (Waldbronn, Germany) equipped with diode-array 
UV detector was used for chromatographic separation. All CEC data was 
recorded and processed by using 3D-CE ChemStation (Rev.A.09.03). The 
Shimadzu (Tokyo, Japan) LC-9A HPLC pump was used for packing and 
flushing capillary columns. Equal pressurization (5~10 bar) on both inlet and 
outlet vials was applied in the system. Buffer pH was measured by a Mettler 
Toledo (Zurich, Switzerland) S20 pH meter. Ultrasonic bath was carried out on 
an Elma Transsonic T820/H sonicator (Singen, Germany). The internal 
column frits and on-column UV detection window were fabricated using a 
resistive heating device from Global Chromatography (Suzhou, China). 
 
 
4.2.3 Preparation of stationary phase materials 
 
The bonded silica particles C[4]CD-HPS was prepared via the successive 
multiple step liquid-solid phase reaction (refer to Section 2.2.3.5) as 
previously reported (Thamarai et al., 2008). Briefly, β-CD was firstly anchored 
onto silica particles at its C(2) position (Gong and Lee, 2002), then derivatized 
primarily at C(6) position by reaction with bromoacetyl bromide to form 
BACD-HPS. Finally, BACD-HPS was reacted with excess calix[4]arene to 
form C[4]CD-HPS (refer to Section 2.2.2.5). Similarly, MCRCD-HPS was 




4.2.4 Preparation of novel CSP-packed CEC columns 
 
The synthesized bonded silica particles C[4]CD-HPS and MCRCD-HPS were 
packed into fused-silica tubing capillary to manufacture 20~30 cm (effective 
length, 28.5-38.5 cm total length) × 75 μm I.D. CEC columns by following 
reported packing procedures (Boughtflower et al., 1995) with modifications. A 
metal frit for micro-HPLC column was temporarily used as the first end frit. 
The packing slurry was prepared by distributing 5~10 mg bonded silica 
particles in 40 µl slurry solvent, the mixture of acetone/IPA (50:50, v/v). A 
illustration of column fabrication is shown in Fig. 4.3. First of all, two ends of 
empty capillary (column) were connected respectively with packing slurry 
chamber and a union with metal frit for micro-HPLC columns. Then the 
capillary was packed with slurry containing synthesized bonded silica particles 
at 350~400 bar. Both slurry chamber and capillary were placed into an 
ultrasonic bath during packing process. Afterwards, the slurry solvent was 
flushed out by ultrapure water (degassed by sonication for 30 min) at 350~400 
bar and the internal column frits (retaining frit and end frit) were sintered. 
Furthermore, the redundant CSP particles packed outside retaining frit was 
removed by flushing water from opposite direction below 10 bar. Finally, the 
on-column detection window was manufactured by gently burning off and 
removing the polyamide coating closed to the retaining frit. At the other end of 




Fig. 4.3. Schematic diagram of CEC column packing procedures. 
 
 
4.2.5 Chromatographic Procedures 
 
The bonded silica particles C[4]CD-HPS and MCRCD-HPS were packed into 
fused-silica capillary by the modified slurry technique (refer to Section 4.2.4). 
The packed CEC columns were flushed with running buffer (mobile phase) for 
at least 4 h before installing in CE instrument. The CEC columns were 
conditioned under the pressure of 5~10 bar on both inlet and outlet vials by 
gradually increasing the applied voltage from 1 kV to at least 5 kV. The 
column temperature was kept at 20 °C during whole operation. All CEC runs 
were performed under pressure to prevent bubble formation in the column. 
The mixture of ACN/Tris-HCl (10 mM, pH = 8), ACN/H3PO4-NaOH (10 mM, 
pH = 8) and ACN/H3PO4-KOH (10 mM, pH = 8) were used as running buffer. 
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The sample concentration in running buffer was 1~5 mg/mL. All running 
buffers and sample solutions were degassed by sonication for at least 5 min 
before use. Each sample was electrokinetically injected under voltage of 3~10 
kV for 3~15 s. The slight mismatch between sample solution and running 
buffer in composition would cause a baseline perturbation which was used as 
EOF marker. All separations were monitored at different UV wavelength 
within 210~310 nm. The reported chromatographic data in this chapter were 
confirmed by duplicate determinations. 
 
 
4.3 Results and discussion 
 
4.3.1 Evaluation of C[4]CD-HPS and MCRCD-HPS 
 
The chromatographic performance of C[4]CD-HPS and MCRCD-HPS was 
investigated before in HPLC by using the mixtures of MeOH/water as mobile 
phases and the positional isomers of disubstituted benzenes (i.e. o-, m-, 
p-nitrophenol and nitroaniline) as solutes. The comparisons for the influence 
of MeOH content in mobile phase on retention behavior of solutes are reported 
before (Thamara et al., 2008). Briefly, the retention factor of all solutes on 
both C[4]CD-HPS and MCRCD-HPS packed columns are increased as the 
MeOH content decreased, which indicate these two stationary phases may 




4.3.2 Enantioseparation on C[4]CD-HPS in CEC 
 
Since one calix[4]arene molecule contains four phenolic hydroxyl groups 
which can be ionized in running buffer, C[4]CD-HPS is able to become 
multiple negatively-charged to provide high EOF in CEC. Therefore, it is 
possible to achieve fast separation on C[4]CD-HPS packed CEC column. The 
typical chromatogram for enantioseparation of 1-phenyl-1-propanol, a 
widely-used choleretic drug compound, on C[4]CD-HPS packed CEC column 
is shown in Fig. 4.4. High enantioselectivity (α = 3.4) with excellent resolution 
(Rs = 2.1) were obtained within 6 min under 6 kV applied voltage. In the 
typical 3D chromatogram for enantioseparation of 1-phenyl-1-propanol as 
shown in Fig. 4.5., two enantiomers of 1-phenyl-1-propanol exhibit similar 
peak profile due to same absorption at different wavelength. The separation 
mechanism is proposed that the hydrophobic portion of 1-phenyl-1-propanol 
was included in the capped β-CD cavity to form an inclusion complex. With 
the dipolar interactions provided by calix[4]arene, whole inclusion complex 
provided excellent enantiomeric recognition. Owing to the cooperative 
function of calix[4]arene and β-CD, fast and high-resolution enantioseparation 
of 1-phenyl-1-propanol was easily achieved on C[4]CD-HPS packed CEC 
column (Zhao et al., 2013). 
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 DAD1 A, Sig=210,16 Ref=off (D:\ZHAOJIA\C4CD-H~1\ZJ90327\28_2.D)
          
      1-phenyl-1-propanol 
        














Fig. 4.4. Chromatogram for enatioseparation of 1-phenyl-1-propanol on 
C[4]CD-HPS packed CEC column.  
 
Conditions: 21 cm (29.5 cm total length) × 75 μm (I.D.) fused-silica 
capillary column, ACN/Tris-HCl (10 mM, pH = 8) (10:90, v/v) as 




Fig. 4.5. 3D chromatogram for enatioseparation of 1-phenyl-1-propanol 
on C[4]CD-HPS packed CEC column.  
 
Conditions: same as Fig. 4.4. 
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As shown in Fig. 4.4., the first enantiomer of 1-phenyl-1-propanol was eluted 
out at 4.8 min while the second one was eluted out at 5.3 min as 
ACN/Tris-HCl (10 mM, pH = 8) (10:90, v/v) used as running buffer. 
Meanwhile, the enantioseparation of 1-phenyl-1-propanol was also achieved 
on other two types of modified β-CD-bonded CSPs previously reported, 
4 '-aminobenzo-15-crown-5-capped ß-CD-bonded sil ica part icles 
(AB15C5-CD-HPS) and mono-(8-benzene-sulfonamidoquinoline-2-ylmethyl)- 
substituted cyclam-capped  β-CD-bonded silica particles (MCCD-HPS) 
under same mobile phase condition (Gong and Lee, 2002; Gong and Lee, 
2003b). Their enantioseparation performance is compared as show in Table 4.2. 
Briefly, similar separation resolutions were achieved on all three types of 
modified β-CD-based CSPs. Interestingly, however, C[4]CD-HPS exhibited 
the highest enantioselectivity with the shortest retention time.  
 
Table 4.2. Comparison of different CSPs for enantioseparation of 




Retention and Separation data 
t1 (min)    t2 (min)      α       RS 
C[4]CD-HPS 4.8        5.3       3.4       2.1 
AB15C5CD-HPS 23.3       26.5       1.4       1.9 
MCCD-HPS 15.3       17.4       1.3       2.1  
 
t1: retention time of the first eluting enaniomer; t2: retention time of the second 




4.3.3 Enantioseparation on MC[4]RCD-HPS in CEC 
 
Compared to calix[4]arene, MCR molecule has more phenolic hydroxyl 
groups which may provide higher EOF in CEC after ionizing in running buffer. 
Therefore, the CEC column packed with MCR-based stationary phases may 
operate under relative low voltage condition and the life of such columns 
would be longer than calix[4]arene-based CEC columns. As shown in Table 
4.3, a wide range of chrial compounds were separated on the MCRCD-HPS 
packed CEC column under different buffer conditions. It is notable that 
inclusion of metal ion (K+ and Na+) from running buffer into CSP would 
improve enantioselectivity and resolution for some solutes. The positively 
charged MCR-CD moiety may provide extra electrostatic interactions with 
ionizable solutes or enhance dipolar interactions with polar neutral solutes to 
strengthen the host–guest interaction. Typical (3D) chromatograms for 
enantioseparation on MCRCD-HPS packed column are shown in Fig. 4.6~ 4.9. 
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Table 4.3. Typical enantioseparation data of chiral compounds on 
MCRCD-HPS packed CEC column.  
 

















10 2.7 1.5 
Benzyl mandelate ACN/Na-Phosphate 
(10:90, v/v) 
10 1.4 0.9 
 ACN/Tris-HCl 
(30:70, v/v) 
6 1.4 1.7 
Dichlorprop ACN/Na-Phosphate 
(10:90, v/v) 
10 1.2 0.6 
Indapamide ACN/Na-Phosphate 
(10:90, v/v) 
10 2.4 4.2 
 ACN/Tris-HCl 
(30:70, v/v) 
8 1.3 0.9 
Indoprofen ACN/Na-Phosphate 
(10:90, v/v) 
10 1.6 2.4 
 ACN/Tris-HCl 
(30:70, v/v) 
8 2.8 2.5 
Ketoprofen ACN/Tris-HCl 
(30:70, v/v) 







Methyl mandelate ACN/Na-Phosphate 
(10:90, v/v) 
10 1.1 1.0 
 ACN/K-Phosphate 
(10:90, v/v) 
10 1.1 1.1 
 ACN/Tris-HCl 
(30:70, v/v) 
8 1.3 1.9 
α-Methylbenzylamine ACN/Na-Phosphate 
(10:90, v/v) 
10 2.2 0.7 
Metoprolol ACN/Na-Phosphate 
(10:90, v/v) 
10 7.0 3.3 
 ACN/K-Phosphate 
(10:90, v/v) 
6 3.1 0.9 
(continue to next page) 
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6 1.1 3.1 
1-(1-naphthyl)ethanol ACN/Na-Phosphate 
(10:90, v/v) 
10 3.1 0.7 
Phenylalanie ACN/Tris-HCl 
(10:90, v/v) 
8 2.1 4.7 
1-Phenyl-1-propanol ACN/Na-Phosphate 
(10:90, v/v) 
10 2.5 1.7 
 ACN/K-Phosphate 
(10:90, v/v) 
6 2.0 1.7 
 ACN/Tris-HCl 
(30:70, v/v) 
8 3.2 2.8 
1-Phenyl-2-propanol ACN/Na-Phosphate 
(10:90, v/v) 
10 1.6 0.4 
 ACN/K-Phosphate 
(10:90, v/v) 
6 1.1 1.4 
 ACN/Tris-HCl 
(30:70, v/v) 
8 1.2 1.0 
Proglumide ACN/Na-Phosphate 
(10:90, v/v) 
10 1.6 2.8 
Promethazine ACN/K-Phosphate 
(10:90, v/v) 
10 2.0 18.0 
Propranolol ACN/Na-Phosphate 
(10:90, v/v) 
10 2.4 1.5 
 ACN/K-Phosphate 
(10:90, v/v) 
10 1.5 7.6 
Warfrain ACN/Na-Phosphate 
(10:90, v/v) 
10 1.3 1.4 
 ACN/K-Phosphate 
(10:90, v/v) 
5 1.4 2.6 
 ACN/Tris-HCl 
(30:70, v/v) 
8 3.7 2.6 
 
25 cm (33.5 cm total length) × 75 μm (I.D.) fused-silica capillary column; 
Running buffer: ACN/Tris-HCl (10 mM, pH = 8), ACN/H3PO4-NaOH (10 mM, 





       Indoprofen 
 












Fig. 4.6. Chromatogram for enatioseparation of indoprofen on MCRCD- 
HPS packed CEC column.  
 
Conditions: 25 cm (33.5 cm total length) × 75 μm (I.D.) fused-silica 
capillary column, ACN /Tris-HCl (10 mM, pH = 8) (30:70, v/v) as 
running buffer , 8 kV, 230 nm UV detection. 
 
 
Fig. 4.7. 3D chromatogram for enatioseparation of indoprofen on 
MCRCD-HPS packed CEC column.  
 
Conditions: same as Fig. 4.6. 
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       α = 1.4, Rs = 1.7 
 
 









Fig. 4.8. Chromatogram for enatioseparation of benzylmandelate on 
MCRCD-HPS packed CEC column.  
 
Conditions: 25 cm (33.5 cm total length) × 75 μm (I.D.) fused-silica 
capillary column, ACN /Tris-HCl (10 mM, pH = 8) (30:70, v/v) as 
running buffer , 6 kV, 230 nm UV detection. 
 
 
Fig. 4.9. 3D chromatogram for enatioseparation of benzylmandelate on 
MCRCD-HPS packed CEC column.  
 
Conditions: same as Fig. 4.8. 
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Compared to the AB15C5-CD-HPS packed column previously reported by our 
group (Gong and Lee, 2002), better enantioselectivity and higher resolution 
were achieved on MCRCD-HPS packed column for a broad range of chiral 
compounds including indapamide (α = 1.9 and Rs = 2.9 on AB15C5-CD-HPS 
versus α = 2.4 and Rs = 4.2 on MCRCD-HPS), 1-phenyl-1-propanol (α = 1.7 
and Rs = 2.7 on AB15C5-CD-HPS versus α = 3.2 and Rs = 2.8 on 
MCRCD-HPS) and propranolol (α = 1.2 and Rs = 1.3 on AB15C5-CD-HPS 
versus α = 1.5 and Rs = 7.6 on MCRCD-HPS). In addition, there is also 
significant improvement in chiral resolution for some chiral compounds like 
nadolol (Rs = 1.1 on AB15C5-CD-HPS versus Rs = 3.1 on MCRCD-HPS). 
Compared to the MCCD-HPS and DCCD-HPS packed columns previously 
reported by our group (Gong and Lee, 2003b), better enantioselectivity and 
higher resolution were achieved on MCRCD-HPS packed column for a broad 
range of chiral compounds including indapamide (α = 1.9 and Rs = 2.9 on 
MCCD-HPS versus α = 2.4 and Rs = 4.2 on MCRCD-HPS), ketoprofen (α = 
1.1 and Rs = 1.2 on MCCD-HPS versus α = 2.4 and Rs = 2.7 on MCRCD-HPS) 
and proglumide (α = 1.1 and Rs = 1.9 on MCCD-HPS versus α = 1.6 and Rs = 
2.8 on MCRCD-HPS). In addition, there is also significant improvement in 
chiral resolution for some chiral compounds like propranolol (Rs = 4.0 on 
DCCD-HPS versus Rs = 7.6 on MCRCD-HPS). These results suggest that 
MCR is a better second chiral recognition site capped on the CD-HPS for the 






Two novel calixarene-capped β-CD-bonded silica particles, C[4]CD-HPS and 
MCRCD-HPS were successfully used as CSP in CEC at the first time. Fast 
baseline separations were easily achieved on the C[4]CD-HPS and 
MCRCD-HPS packed CEC columns. High enantioselectivity and excellent 
resolution were obtained on both CSPs result from the cooperative function of 
calixarene and β-CD. Compared to AB15C5-CD-HPS and MCCD-HPS, 
C[4]CD-HPS and MCRCD-HPS exhibite better enantioselectivity and 
resolution than AB15C5-CD-HPS and MCCD-HPS for a wide range of chiral 
compounds. In addition, CEC column packed with calixarene capped 
β-CD-bonded type CSPs could operate under relative low voltage which 













APPLICATION OF MCR-HPS AND BAMCR-HPS AS 




The success of C[4]CD-HPS and MCRCD-HPS as CSPs in CEC indicates that 
calixarenes is capable to apply in novel CSPs with multiple chiral recognition 
sites, especially the modified calixarene-based CSPs. In this chapter, two novel 
MCR-bonded silica particles, MCR-HPS and BAMCR-HPS, are introduced as 
CSPs in HPLC for enantioseparation. Their enantioselectivity in HPLC were 
investigated under different chromatography modes with varied mobile phase 
conditions. In addition, the enantioseparation performance of MCR-HPS and 





5.2.1 Reagents and materials 
 
The reagents and starting materials were purchased from commercial 





A Shimadzu (Kyoto, Japan) LC20AT system equipped with LC20AT pumps, 
CBM-20A controller and SPDM20A photo diode array (PDA) detector was 
used for chromatographic separation. LCsolution software (Rev. 1.24 sp1) was 
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used to record and process all chromatographic data. 
 
 
5.2.3 Preparation of stationary phase materials 
 
The bonded silica particles MCR-HPS and BAMCR-HPS were prepared via 
the successive multiple step liquid-solid phase reaction on silica as reported 
(Tan et al., 2011). Briefly, MCR was anchored onto silica particles to form 
MCR-HPS (refer to Section 2.2.4.1) which was then reacted with bromoacetyl 
chloride to form BAMCR-HPS (refer to Section 2.2.4.3). 
 
 
5.2.4 Preparation of novel CSP-packed HPLC columns 
 
The HPLC columns were prepared by the slurry packing method. The 
procedures are similar to Section 3.2.4. 
 
 
5.2.5 Chromatographic procedures 
 
The synthesized bonded silica particles MCR-HPS and BAMCR-HPS were 
packed into 150 mm × 2.0 mm I.D. stainless steel columns (Phenomenex, 
Torrance, CA, USA) by the modified slurry method (refer to Section 3.2.4). 
The packed HPLC columns were preconditioned by each mobile phase for at 
least 1 h before chromatographic application. The TEAA buffer was prepared 
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as standard procedures (refer to Section 3.2.5). The mixtures of MeOH/H2O, 
ACN/H2O and ACN/TEAA buffer solutions with different volume ratios were 
used as mobile phases, which were degassed by sonication for at least 45 min 
before use. All samples were prepared by dissolving in MeOH or ACN at the 
concentrations of 0.5~5 mmol/L and then degassed by sonication for at least 
10 min before injection. The injection volume of each analysis was 5~10 μl 
while HPLC was carried out at room temperature. The baseline perturbations 
caused by the injection of mobile phase were used as void volume marker (t0) 
for separation data analysis. All separations were monitored at different UV 
wavelengths (210 nm, 230 nm, 254 nm and 280 nm). The reported 




5.3 Results and discussion 
 
5.3.1 Evaluation of MCR-HPS and BAMCR-HPS 
 
The chromatographic performance of MCR-HPS and BAMCR-HPS was 
investigated by using MeOH/H2O and IPA/hexane mixtures as mobile phases 
and the positional isomers of disubstituted benzenes as solutes.  
 
The comparisons for the influence of MeOH content in mobile phase on 
retention behavior of solutes are shown in Table 5.1. Briefly, the retention 
factor (k) of all solutes on both MCR-HPS and BAMCR-HPS packed columns 
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are increased as the MeOH content decreased, which indicate these two 
stationary phases may have hydrophobic interaction with solutes. Briefly, 
MCR-HPS exhibited higher retention while BAMCR-HPS showed better 
separation. For nitroaniline isomers, m-nitroaniline was always the first one to 
elute out on both MCR-HPS and BAMCR-HPS packed columns. Meanwhile, 
p-nitroaniline eluted out last on MCR-HPS packed column while 
o-nitroaniline eluted out last on BAMCR-HPS packed column. The results are 
different from the commercial octadecylsilane (ODS) column which elution 
order is p < m < o (Liu et al., 2005). For nitrophenol isomers, the elution order 
on BAMCR-HPS packed column was p < m < o, which is same as the ODS 
column. On MCR-HPS packed column, however, the elution order is p < m < 
o and changed to p < o < m when the methanol content reduced to 40% or less. 
The comparison for the influence of MeOH content in mobile phase on 
retention behavior of solutes (Tan ea al., 2011) is shown in Table 5.1. Besides 
hydrophobic interaction, the results indicate there are other interactions on 
both MCR-HPS and BAMCR-HPS like host-guest interaction or 
hydrogen-bonding interaction. 
 
Interestingly, positional isomers of nitrophenol and nitroaniline can also be 
separated on both MCR-HPS and BAMCR-HPS packed columns by using the 
mixtures of hexane/IPA as mobile phase. The typical chromatograms to 
compare the separations of nitroaniline on BAMCR-HPS packed column 
under different mobile phases are shown in Fig. 5.1. The elution order of the 
nitroaniline isomers at IPA/hexane (typical normal-phase chromatography 
mode) condition is o < m < p, which is different from the m < p < o under 
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MeOH/H2O (typical reversed-phase chromatography mode) condition. This 
difference indicates that multiple interactions like π- π interaction, hydrogen 
bonding or host-guest interaction play a key role for separation under 
normal-phase chromatography mode. Therefore, there are separation 




Table 5.1. Retention factors (k) for positional isomers of nitroaniline and 
nitrophenol on MCR-HPS and BAMCR-HPS packed HPLC columns 
under varied MeOH/H2O proportions. 
 
Solutes 
MeOH : H2O (v/v) 
CSP 
80:20 60:40 40:60 20:80 
o-Nitroaniline 
0.6 0.8 1.3 2.3 MCR-HPS 
0.2 0.3 0.7 1.4 BAMCR-HPS 
      
m-Nitroaniline 
0.6 0.7 1.1 1.8 MCR-HPS 
0.2 0.3 0.6 1.1 BAMCR-HPS 
      
p-Nitroaniline 
0.7 0.8 1.3 2.5 MCR-HPS 
0.2 0.3 0.7 1.4 BAMCR-HPS 
      
o-Nitrophenol  
0.6 0.7 0.9 1.3 MCR-HPS 
0.2 0.3 0.6 1.1 BAMCR-HPS 
      
m-Nitrophenol 
0.5 0.7 0.9 1.4 MCR-HPS 
0.2 0.2 0.5 0.9 BAMCR-HPS 
      
p-Nitrophenol 
0.5 0.5 0.7 0.8 MCR-HPS 
0.1 0.2 0.5 0.8 BAMCR-HPS 
 
MCR-HPS and BAMCR-HPS packed columns at 150 mm × 2.0 mm (I.D.); 






Fig. 5.1. Chromatograms for separation of o-, m-, p- nitroaniline on 
BAMCR-HPS packed column at (top) MeOH/H2O (10:90, v/v) 




5.3.2 Enantioseparation on MCR-HPS in HPLC 
 
The chromatographic performance of the MCR-HPS packed HPLC column for 
enantioseparation of chiral compounds was studied under different 
chromatography mode with varied mobile phase conditions. Only few chiral 
compounds were resolved as partial enantioseparation on the MCR-HPS 
packed column. The main reason is supposed the size of native MCR molecule 
only suitable for relative small analyte molecules for formation of host-guest 
complex. This situation could be improved by further modification of MCR to 
enlarge the host molecule size to improve separation performance thereafter. 
Table 5.2 lists the best separation data for each chiral compound with the 
mobile phase employed. 
 
Table 5.2. Typical enantioseparation data of chiral compounds on 
MCR-HPS packed HPLC column. 
 
 
k1: retention factor for the first enantiomer eluted out; α: enantioselectivity;  




















1-(1-Naphthyl)ethylamine ACN/TEAA, pH = 7 
(99:1, v/v) 
0.2 1.1 0.6 
Nadolol IPA/hexane 
(3:97, v/v) 
0.7  1.1 0.4 
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5.3.3 Enantioseparation on BAMCR-HPS in HPLC 
 
The chromatographic performance of BAMCR-HPS packed HPLC column for 
enantioseparation of chiral compounds was studied under different 
chromatography mode with different mobile phase conditions. A wide range 
of chiral compounds including amino acids, β-blockers, NSAIDs, etc., were 
resolved on the BAMCR-HPS packed column. Table 5.3 lists the best 
separation data for each chiral compound with the mobile phase employed. 
Briefly, BAMCR-HPS exhibited much better enantioselectivity and resolution 
than MCR-HPS at similar mobile phase conditions. This improvement 
indicates that the bromoacetate groups in BAMCR-HPS played a key role for 
enantioseparation which is similar to the effect of bromoacetate groups in 
BACD-HPS reported before (Thamarai et al., 2010). Typical chromatograms 
of enantioseparations on BAMCR-HPS packed column are shown in Fig. 5.2 
and Fig. 5.3. 
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Table 5.3. Typical enantioseparation data of chiral compounds on 
BAMCR-HPS packed HPLC column. 
  
 
k1: retention factor for the first enantiomer eluted out; α: enantioselectivity;  




























3.6 1.5 2.1 
1-Phenyl-1-propanol MeOH/H2O 
(20:80, v/v) 
1.4 1.9 2.8 
Zearalanol MeOH/H2O 
(20:80, v/v) 
0.6 1.6 0.8 
Zearalenol MeOH/H2O 
(20:80, v/v) 
0.7 1.4 0.6 
Ketoprofen ACN/H2O 
(80:20, v/v) 
0.5 1.4 0.8 
α-Methylbenzylamine ACN/TEAA, pH = 4 
(99:1, v/v) 
1.3 2.1 2.7 
Phenylalanine ACN/TEAA, pH = 7 
(99:1, v/v) 
0.5 2.1 1.4 
Aminoglutethimide ACN/TEAA, pH = 7 
(99:1, v/v) 
1.1 3.8 4.7 
Proglumide ACN/TEAA, pH = 7 
(99:1, v/v) 
1.0 3.0 3.6 
1-(1-Naphthyl)ethylamine ACN/TEAA, pH=7 
(99:1, v/v) 
0.7 1.3 1.3 
Nadolol IPA/hexane 
(3:97, v/v) 
0.2 3.0 0.8 
1-Phenyl-1-pentanol IPA/hexane 
(3:97, v/v) 




Fig. 5.2. Chromatogram for enantioseparation of α-methylbenzylamine on 
BAMCR-HPS packed HPLC column. 
 
Conditions: 150 mm × 2.0 mm (I.D.) column,  




Fig. 5.3. Chromatogram for enantioseparation of indapamide on   
BAMCR-HPS packed HPLC column. 
 
Conditions: 150 mm × 2.0 mm (I.D.) column,  





Compared to the BACD-HPS packed HPLC column previously reported by 
our group (Thamarai et al., 2010), better enantioselectivity and higher 
resolution were achieved on BAMCR-HPS packed column for a broad range 
of chiral compounds including aminoglutethimide (α = 1.5 and Rs = 1.0 on 
BACD-HPS versus α = 3.8 and Rs = 4.7 on BAMCR-HPS), 
1-phenyl-1-propanol (α = 1.4 and Rs = 1.4 on BACD-HPS versus α = 1.9 and 
Rs = 2.8 on BAMCR-HPS) and proglumide (α = 1.6 and Rs = 0.4 on 
BACD-HPS versus α = 3.0 and Rs = 3.6 on BAMCR-HPS) under similar 
mobile phase conditions. In addition, there was also significant improvement 
in chiral resolution or enantioselectivity for some chiral compounds like 
proglumide (Rs = 2.5 on BACD-HPS versus Rs = 2.7 on BAMCR-HPS) and 
nadolol (α = 2.8 on BACD-HPS versus α = 3.0 on BAMCR-HPS) under 
similar mobile phase conditions. These results indicate that BAMCR-HPS is 
better than BACD-HPS (or MCR is better than CDs) for enantioseparation of 
the chiral compounds mentioned.  
 
The main chiral recognition mechanism of BAMCR-HPS is proposed that 
hydrophobic portion of solute is included in MCR cavity while hydroxyl 
groups and bromoacetate groups of MCR provide further interactions, such as 





Two novel MCR-bonded silica particles, MCR-HPS and BAMCR-HPS, were 
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successfully applied as CSPs for HPLC to separate aromatic positional 
isomers and chiral compounds. Their chromatographic performance suggests 
they are of notable advantages and potential for enantioseparation for a wide 
range of chiral drugs. Meanwhile, there is not significant change in the 
chromatographic performance of MCR-HPS and BAMCR-HPS packed HPLC 
columns observed after continuous usage over half year, especially under the 
mobile phase conditions containing TEAA buffer, which indicate that both 
CSPs are fairly robust. However, some chiral compounds were only partial 
separated on MCRHPS and BAMCR-HPS. Further modification on 










APPLICATION OF RMCR-HPS AND 





The success of MCR-HPS and BAMCR-HPS as CSPs in HPLC indicates that 
MCR-based CSPs are capable to apply in novel CSPs with multiple chiral 
recognition sites. In this chapter, two novel modified MCR-bonded silica 
particles, RMCR-HPS and 15C5-MCR-HPS, are introduced as CSPs in HPLC 
and CEC for (enatio)separation. Their enantioselectivity in HPLC were 
different chromatography modes with varied mobile phase conditions. In 
addition, the enantioseparation performance of RMCR-HPS and 





6.2.1 Reagents and Materials 
 
The Tris-HCl buffer was prepared as standard procedures (refer to Section 
3.3.1). The rest reagents and starting materials were purchased from 






An Agilent Technologies (Waldbronn, Germany) Model1100 system equiped 
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with binary pump, auto sampler and multiple wave-length UV detector was 
used for chromatographic separation on the RMCR-HPS and 15C5-MCR-HPS 
packed HPLC columns. Chemstation software (Rev.A.09.03) was used to 
record and process all chromatographic data. 
. 
An Agilent 3D-CE system (Waldbronn, Germany) equipped with a diode-array 
UV detector was used for chromatographic separation on the RMCF-HPS 
packed CEC column. CEC data was recorded and processed by using 3D-CE 
ChemStation (Rev.A.09.03). A Shimadzu (Tokyo, Japan) LC-9A HPLC pump 
was used for packing and flushing the capillary columns. An equal 
pressurization (5~10 bar) of both inlet and outlet vials was applied in the 
system. Buffer pH was measured by a Mettler Toledo (Zurich, Switzerland) 
S20 pH meter. Ultrasonic bath was carried out on an Elma Transsonic T820/H 
sonicator (Singen, Germany). The internal column frits and on-column UV 
detection window were fabricated using a resistive heating device from Global 
Chromatography (Suzhou, China). 
 
 
6.2.3 Preparation of stationary phase materials 
 
The bonded silica particles RMCR-HPS and 15C5-MCR-HPS were prepared 
via the successive multiple step liquid-solid phase reaction. Briefly, 
BAMCR-HPS was reacted with excess rifamycin SV to form RMCR-HPS 
(refer to Section 2.2.4.4). Similarly, 15C5-MCR-HPS were prepared by 
treating BAMCR-HPS with 15C5 (refer to Section 2.2.4.5). 
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6.2.4 Preparation of novel CSP-packed CEC and HPLC columns 
 
The HPLC and CEC columns were prepared by the slurry packing method. 
The procedures are similar to Section 3.2.4 and Section 4.2.4 respectively. 
 
 
6.2.5 Chromatographic procedures 
 
The synthesized bonded silica particles ODS-MCR-HPS, RMCR-HPS and 
15C5-MCR-HPS were packed into 150 mm × 2.0 mm I.D. stainless steel 
columns (Phenomenex, Torrance, CA, USA) by the modified balance-density 
slurry method (refer to Section 3.2.4). The packed HPLC columns were 
preconditioned by mobile phase for at least 1 h before chromatographic 
application. The TEAA buffer was prepared as standard procedures (refer to 
Section 3.2.5). The mixtures of MeOH/H2O, ACN/H2O and ACN/TEAA 
buffer solutions with different volume ratios were used as mobile phases, 
which were degassed by sonication for at least 45 min before use. All samples 
were prepared by dissolving in MeOH or ACN at the concentrations of 0.5~5 
mmol/L and then degassed by sonication for at least 10 min before injection. 
The injection volume of each analysis was 5~10 μl while HPLC was carried 
out at room temperature. The baseline perturbations caused by the injection of 
mobile phase were used as void volume marker (t0) for separation data 
analysis. All separations were monitored at different UV wavelengths (210 nm, 
230 nm, 254 nm and 280 nm).  
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The bonded silica particles RMCR-HPS was packed into the fused-silica 
capillary by the modified slurry method (refer to Section 4.2.4). The packed 
CEC columns were flushed with running buffer for at least 4 h before 
installing in CE instrument. The CEC columns were conditioned under the 
pressure of 5~10 bar on both inlet and outlet vials by gradually increasing the 
applied voltage from 1 kV to at least 5 kV. The column temperature was kept 
at 20 °C during operation. All CEC runs were performed under pressure to 
prevent bubble formation in the column. The mixture of ACN/Tris-HCl (10 
mM, pH = 8) (10:90, v/v) were used as running buffer. The sample 
concentration in running buffer was 1~5 mg/mL. All running buffers and 
sample solutions were degassed by sonication for at least 5 min before use. 
Each sample was injected electrokinetically by applying a voltage of 3~10 kV 
for 3~15 s. The slight mismatch between sample solution and running buffer in 
composition caused a baseline perturbation which was used as EOF marker. 
All separations were monitored at different UV wavelength in 210~310 nm. 
The reported data in this chapter were confirmed by duplicate determinations. 
 
 
6.3 Results and discussion 
 
6.3.1 Evaluation of RMCR-HPS and 15C5-MCR-HPS 
 
The chromatographic performance of RMCR-HPS and 15C5-MCR-HPS was 
investigated by using MeOH/H2O and IPA/hexane mixtures as mobile phases 
and the positional isomers of disubstituted benzenes as solutes. The 
comparisons for the influence of MeOH content in mobile phase on retention 
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behavior of solutes are shown in Table 6.1. Briefly, the retention factor of all 
solutes on all three packed columns are increased as the MeOH content 
decreased, which indicate these two stationary phases may have hydrophobic 
interaction with solutes. 
 
 
Table 6.1. Retention factors (k) for positional isomers of nitroaniline and 
nitrophenol on RMCR-HPS and 15C5-MCR-HPS packed 
HPLC columns under varied MeOH/H2O proportions.  
 
Solutes 
MeOH : H2O (v/v) 
CSP 
100:0 80:20 60:40 40:60 20:80 
o-Nitroaniline 
0.7 1.2 1.7 2.7 4.8 RMCR-HPS 
0.1 0.5 1.1 1,9 4.5 15C5-MCR-HPS 
 
m-Nitroaniline 
0.1 0.5 0.7 0.8 1.0 RMCR-HPS 
0.2 0.5 1.1 1.7 3.7 15C5-MCR-HPS 
       
p-Nitroaniline 
0.8 1.3 1.7 2.6 4.6 RMCR-HPS 
0.2 0.5 1.0 1.9 4.5 15C5-MCR-HPS 
       
o-Nitrophenol 
0.1 0.4 0.5 0.6 0.9 RMCR-HPS 
0.1 0.4 1.0 1.7 3.4 15C5-MCR-HPS 
       
m-Nitrophenol 
0.7 1.2 1.7 2.5 3.6 RMCR-HPS 
0.1 0.4 0.9 1.4 2.8 15C5-MCR-HPS 
       
p-Nitrophenol 
0.1 0.4 0.5 0.6 0.7 RMCR-HPS 
0.1 0.4 1.1 1.4 2.0 15C5-MCR-HPS 
 
15C5-MCR-HPS packed column at 150 mm × 2.0 mm (I.D.); RMCR-HPS 
packed columns at 100 mm ×2.0 mm (I.D.); UV detection at 254nm. 
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Table 6.2. Retention factors (k) for positional isomers of nitroaniline and 
nitrophenol on RMCR-HPS and 15C5-MCR-HPS packed 
HPLC columns under varied IPA/hexane proportions.  
 
Solutes 
IPA : hexane (v/v) 
CSP 
30:70 15:85 10:90 5:95 3:97 
o-Nitroaniline 
0.8 1.4 2.0 2.8 4.2 RMCR-HPS 
0.9 2.1 3.0 4.4 5.1 15C5-MCR-HPS 
 
m-Nitroaniline 
      
6.5 8.7 11.2 13.7 16.5 RMCR-HPS 
8.8 19.8 22.5 46.1 48.8 15C5-MCR-HPS 
 
p-Nitroaniline 
      
2.4 6.5 12.3 23.2 30.3 RMCR-HPS 
3.8 6.4 7.6 13.3 15.6 15C5-MCR-HPS 
 
o-Nitrophenol  
      
0.2 0.3 0.4 0.5 0.6 RMCR-HPS 
0.5 0.7 0.9 1.2 1.4 15C5-MCR-HPS 
 
m-Nitrophenol 
      
0.3 0.6 0.9 1.7 2.9 RMCR-HPS 
0.7 1.3 1.7 2.7 3.1 15C5-MCR-HPS 
 
p-Nitrophenol 0.4 0.8 1.6 3.6 3.8 RMCR-HPS 
1.0 2.1 2.7 5.4 6.6 15C5-MCR-HPS 
 
15C5-MCR-HPS packed column at 150 mm × 2.0 mm (I.D.); RMCR-HPS 
packed columns at 100 mm ×2.0 mm (I.D.); UV detection at 254nm. 
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6.3.2 Enantioseparation on RMCR-HPS in HPLC and CEC 
 
The chromatographic performance of the RMCR-HPS packed HPLC column 
for enantioseparation of chiral compounds was studied under different 
chromatography mode with varied mobile phase conditions. Several chiral 
compounds were resolved on the RMCR-HPS packed column. Table 6.3 lists 
the best separation data for each chiral compound with the mobile phase 
employed. 
 
Table 6.3. Typical enantioseparation data of chiral compounds on     




k1: retention factor for the first enantiomer eluted out; α: enantioselectivity;  




















0.1 6.4 2.5 
1-Phenyl-1-propanol ACN/H2O 
(5:95, v/v) 
0.4 3.1 2.6 
1-(1-Naphthyl)ethylamine ACN/H2O 
(30:70, v/v) 
0.8 1.6 1.3 
Warfarin IPA/hexane 
(3:97, v/v) 
1.7 1.5 1.9 
α-Methylbenzylamine  ACN/TEAA, pH = 7 
(5:95,v/v) 
0.4 7.1 5.7 
Promethazine ACN/TEAA, pH = 7 
(5:95,v/v) 
2.3 2.2 3.9 
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                                 1-phenyl-1-propanol 
 












Fig. 6.1. Chromatogram for enantioseparation of 1-phenyl-1-propanol on 
RMCR-HPS packed HPLC column. 
 
Conditions: 100 mm × 2.0 mm (I.D.) column,  




                Warfarin 
 











Fig. 6.2. Chromatogram for enantioseparation of warfarin on 
RMCR-HPS packed HPLC column. 
 
   Conditions: 100 mm × 2.0 mm (I.D.) column,  
   IPA/hexane (3:97, v/v) as mobile phase 
 
Compared to the BAMCR-HPS packed column previously reported (Tan et al., 
2011), better enantioselectivity and higher resolution were achieved on 
RMCR-HPS packed column for a broad range of chiral compounds including 
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α-methylbenzylamine (α = 2.1 and Rs = 2.7 on BAMCR-HPS versus α = 7.1 
and Rs = 5.7 on RMCR-HPS), 1-phenyl-1-pentanol (α = 1.3 and Rs = 1.2 on 
BAMCR-HPS versus α = 3.2 and Rs = 2.8 on RMCR-HPS) and warfarin (no 
separation on BAMCR-HPS versus α = 1.5 and Rs = 1.9 on RMCR-HPS) 
under similar mobile phase conditions. In addition, there was also significant 
improvement in enantioselectivity for some chiral compounds like 
1-(1-naphthyl)ethanol (α = 1.3 on BAMCR-HPS versus α = 1.6 on 
RMCR-HPS), 1-pheny1-1,2-ethanediol (α = 4.5 on BAMCR-HPS versus α = 
6.4 on RMCR-HPS) and 1-phenyl-1-propanol (α = 1.9 on BAMCR-HPS 
versus α = 3.1 on RMCR-HPS) under similar mobile phase conditions. These 
results indicate that rifamycin plays an important role in RMCR-HPS to 
improve chiral recognition for higher coverage of chiral compounds, and also 
indirectly prove the successful synthesis of RMCR-HPS. 
 
Typical chromatogram for enantioseparation of 1-phenyl-1-propanol and 
1-phenyl-2-propanol on RMCR-HPS packed CEC column are shown in Fig. 
6.3 and Fig. 6.4. Owing to the cooperative function of the rifamycin and MCR, 
fast and high-resolution enantioseparation were achieved. 
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Fig. 6.3. Chromatogram for enatioseparation of 1-phenyl-1-propanol on 
RMCR-HPS packed CEC column.  
 
Conditions: 26.5 cm (35 cm total length) × 75 μm (I.D.) fused-silica 
capillary column, ACN/Tris-HCl (10 mM, pH = 8) (30:70, v/v) as 




      1-phenyl-2-propanol 
 












Fig. 6.4. Chromatogram for enatioseparation of 1-phenyl-2-propanol on 
RMCR-HPS packed CEC column.  
 
Conditions: 25 cm (33.5 cm total length) × 75 μm (I.D.) fused-silica 
capillary column, ACN/Tris-HCl (10 mM, pH = 8) (30:70, v/v) as 




6.3.3 Enantioseparation on 15C5-MCR-HPS in HPLC 
 
The chromatographic performance of 15C5-MCR-HPS packed HPLC column 
for enantioseparation of chiral compounds was studied under different 
chromatography mode with different mobile phase conditions. A wide range 
of chiral compounds including amino acids, β-blockers, NSAIDs, etc., were 
resolved on the BAMCR-HPS packed column. Table 6.4 lists the best 
separation data for each chiral compound with the mobile phase employed.  
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Table 6.4. Typical enantioseparation data of chiral compounds on 
15C5-MCR-HPS packed HPLC column. 
 
 
k1: retention factor for the first enantiomer eluted out; α: enantioselectivity;  























2.3 2.2 4.5 
Propanolol MeOH/H2O 
(40:60, v/v) 
2.6 1.3 1.3 
Warfarin MeOH/H2O 
(40:60, v/v) 
7.2 2.0 4.5 
Benzyl mandelate ACN/H2O 
(5:95, v/v) 
1.4 3.1 4.1 
Methyl mandelate ACN/H2O 
(5:95, v/v) 





0.1 4.8 1.3 
1-Pheny1-1,2-ethanediol ACN/H2O 
(5:95, v/v) 
0.3 4.4 1.3 
Ibuprofen ACN/H2O 
(10:90, v/v) 
0.3 12.3 5.9 
Indapamide ACN/H2O 
(10:90, v/v) 
2.4 1.8 2.3 
α-Methylbenzylamine ACN/H2O 
(10:90, v/v) 
1.1 1.7 1.7 
Promethazine ACN/H2O 
(30:70, v/v) 




pH = 7.2 (5:95,v/v) 
0.5 2.2 2.1 
Clomiphene ACN/MeOH/TEAA, 
pH = 8.3 
(90:10:0.004:0.004, 
v/v/v/v) 
5.4 1.1 0.6 
1-(1-Naphthyl)ethylamine ACN/MeOH/TEAA, 
pH = 8.3 
(90:10:0.004:0.004, 
v/v/v/v) 
0.2 1.8 1.7 
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Compared to the BAMCR-HPS packed column previously reported (Tan et al., 
2011), better enantioselectivity and higher resolution were achieved on 
15c5-MCR-HPS packed column for a broad range of chiral compounds 
including benzyl mandelate (no separation on BAMCR-HPS versus α = 3.1 
and Rs = 4.1 on 15C5-MCR-HPS), ibuprofen (no separation on BAMCR-HPS 
versus α = 12.3 and Rs = 5.9 on 15C5-MCR-HPS), indapamide (α = 1.5 and 
Rs = 2,1 on BAMCR-HPS versus α = 1.8 and Rs = 2.3 on RMCR-HPS), 
methyl mandelate (no separation on BAMCR-HPS versus α = 2.6 and Rs = 2.2 
on 15C5-MCR-HPS), 1-(1-naphthyl)ethylamine (α = 1.3 and Rs = 1.3 on 
BAMCR-HPS versus α = 1.8 and Rs = 1.7 on 15C5-MCR-HPS), metoprolol 
(no separation on BAMCR-HPS versus α = 4.8 and Rs = 1.3 on 
15C5-MCR-HPS), promethazine (no separation on BAMCR-HPS versus α = 
7.0 and Rs = 7.4 on 15C5-MCR-HPS) and warfarin (no separation on 
BAMCR-HPS versus α = 2.0 and Rs = 4.5 on 15C5-MCR-HPS) under similar 
mobile phase conditions. These results indicate that 15C5 plays an important 
role in 15C5-MCR-HPS to improve chiral recognition for higher coverage of 






Two novel modified MCR-bonded silica particles, RMCR-HPS and 
15C5-MCR-HPS, were successfully applied as CSPs for HPLC to separate 
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aromatic positional isomers and chiral compounds. Their chromatographic 
performance suggests they are of notable advantages and potential in 
enantioseparation for a wide range of chiral drugs. Meanwhile, there is no 
significant change in the chromatographic performance of RMCR-HPS and 
15C5-MCR-HPS packed HPLC columns observed after continuous usage over 
















A series of novel antibiotic-capped macrocycle-bonded silica particles, 
RCD-HPS, VCD-HPS, C[4]CD-HPS, MCRCD-HPS, RMCR-HPS and 
15C5-MCR-HPS, were successfully synthesized by successive multiple step 
liquid solid phase reaction, and applied as CSPs in HPLC and CEC. 
 
These CSPs have multiple chiral recognition sites with many different 
functional moieties including vancomycin, rifamycin, β-CD, crown ether and 
types of calixarenes. Their structures were characterized by means of analysis 
methods including SEM/EDX, MS, elemental analysis and FTIR. 
 
Owing to the cooperative function of antibiotics and anchored macrocycle 
moieties, these novel CSPs exhibited excellent chromatographic selectivity for 
separation of positional isomers of disubstituted benzenes and enantiomers of 
a wide range of chiral drug compounds in HPLC and CEC under varied 
mobile phase conditions. 
 
 
7.2 Limitation and prospects 
 
The novel CSPs in this dissertation were prepared by multiple step liquid solid 
phase reactions. The synthesis method can be improved by optimization of 
reaction parameters like time and temperature, isolation and purification of 
intermediate product synthesized like MCR-HP. 
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Based on the van Deemter equation, there is a significant improvement in 
separation efficiency when the particle size decreased to 2.5 μm or less. 
Meanwhile, column efficiency is not diminished at increased flow rate or linear 
velocity. Thus, separation speed and peak capacity will extend to the new 
limitations as smaller particles used. This method takes full advantage of 
chromatographic principles for separations by using the column packed smaller 
particles with higher flow rates to achieve superior resolution and sensitivity. In 
particular, preparing novel CSPs based on sub 2-μm and core-shell (solid core) 
particles will significant stimulate the development. The gain in separation 
efficiency achievable will definitely be beneficial also for chiral separations. 
Since the first sub-2 μm CSP reported (Cancelliere, 2010), it can be expected 
that an outstanding production of HPLC columns packed with already known or 
new CSPs would be marketed soon. 
 
For HPLC, fast separation is always a challenges which often leads to high 
operation pressure. Therefore, ultra high pressure liquid chromatography is 
developed to fulfil the much stricter requirements on pumping and flow 
system for high-pressure operation (Hayes et al., 2014). 
 
Compared to HPLC, the preparation of CEC column is always a challenge 
though many manufacture methods reported. For the packed-column CEC, the 
most serious obstacle is bubble formation within the packed column arising 
from the on-column frits during the operation, which often leads to a poor 
baseline, irreproducible retention times and even current breakdown or no 
peak. Meanwhile, packed columns suffer from time-consuming fabrication 
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procedures, poor permeability and fragility. These limitations associated with 
packed columns have stimulated the development of alternative column 
technologies. Among the various approaches, monolithic columns or 
continuous-bed columns has recently attracted increasing interest. A 
monolithic column is typically a continuous porous solid anchored to the 
capillary wall, which is prepared through in situ polymerization or 
consolidation inside the column. The stationary phase could be attached on the 
monolithic surface or embedded in the monolithic matrix. The attraction of 
monolithic CEC columns is partially due to the fact that no frits are necessary 
to keep the stationary phase in place. Therefore the problem of bubble 
formation arising from the frits in packed columns could be avoided. 
Compared with open-tubular columns, the monolithic columns have much 
higher surface areas and adsorption capacities and thus the sample loading 
could be significantly improved. Owing to high permeability, the separation 
speed is enhanced in monolithic columns and the requirement of high-pressure 
conditioning with an HPLC pump is eliminated. Currently, various procedures 
and a wide variety of precursors offer valuable flexibility of the surface 
chemistry for monolithic columns (Subramanian, 2007). 
 
The preparative separation of chiral drugs and intermediates on CSPs is 
increasingly becoming an alternative to enantioselective synthetic routes, 
mainly due to advantages with regard to time and reliability of scale-up. 
Advances in chromatographic techniques, such as recycling/peak shaving, 
automated repetitive injection mode and simulated moving bed (SMB) 
chromatography are further reasons. Recycling/peak shaving and SMB 
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chromatography require less stationary phase and solvent and, therefore, offer 
higher specific productivity.  
 
Novel CSPs with wide application area will stimulate the development and 
production of chiral drugs. For example, paclitaxel is a medication used to 
treat ovarian cancer, breast cancer and many other types of cancer. It is the 
crude extract from the bark of Pacific yew with relatively low but highly 
variable yields. Total synthesis method coupled with necessary purification by 
chromatographic methods with novel CSPs has been studied for decades to 
instead of current production methods like plant cell fermentation technology 
or semi-synthesis. 
 
Beside vancomycin and rifamycin, there are several macrocylic molecules 
which are capable to be used for developing novel CSPs with multiple chiral 
recognition sites. Same as vancomycin, eremomycin is a macrocylic 
glycopeptides antibiotic. The eremomycin molecule has two amino sugar 
residues while vancomycin has one. There are three cavities, three sugar 
moieties, five aromatic rings, nine hydroxyl groups, seven amido groups, three 
amino groups, one carboxylic group with totally twenty two chiral centers in the 
eremomcyci molecule. Different from vancomycin, eremomycin has different 
structure with trinucleus amino acid fragment, in which eremomycin has one 
chloro-substituted aromatic ring while vancomycin has two (Staroverov et al., 
2006). Similar to CDs, cyclofructans is cyclic oligosaccharides and the newest 
class of chiral stationary phases for LC. Currently, there are commercial 
derivatized cyclofructans-based columns available. It was reported that this 
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kind column works more effectively with organic solvents and supercritical 
fluids with great capability for preparative-scale separations. Therefore, 
eremomycin and cyclofructans are interested us to employ them as new chiral 
recognition sites in novel CSPs for future work. 
 
Meanwhile, our group attempted a new type of mixed octadecylsilyl- and 
(3-(C-methylcalix[4]resorcinarene)-2-hydroxypropoxy)-propylsilyl-bonded 
silica particles (ODS-MCR-HPS) which was used as stationary phase for HPLC 
(Tan et al., 2012). The octadecylsilyl (ODS) columns is widely used in 
reversed-phase HPLC mode owing to its excellent reproducibility and 
versatility, but limited in certain separations, for example, poor selectivity of 
positional isomers of disubstituted benzenes (Liu et al, 2005). Interestingly, the 
ODS-MCR-HPS column exhibits excellent selectivity for the separation of 
positional isomers of disubstituted benzenes and the mixtures of some aromatic 
hydrocarbon compounds, due to the cooperative and complementary 
functioning of ODS and MCR under different mobile phase conditions. Thus, 
ODS-MCR-HPS is a success experiment which indicates the possibility to 
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